ID

DB00241|APRD00266||

名称

Butalbital

描述

Butalbital, or 5-allyl-5-isobutylbarbituric acid, is a derivative of barbituric acid which the hydrogens at position 5 are substituted by an allyl group and an isobutyl group. It is a short-to-intermediate acting member of barbiturates that exhibit muscle-relaxing and anti-anxiety properties that produce central nervous system (CNS) depression that ranges from mild sedation to general anesthesia.[A177754] Butalbital has a low degree of selectivity and a narrow therapeutic index.[A177754] Typically indicated to manage tension (or muscle contraction) headaches, butalbital is often combined with one or more therapeutic agents, such as acetylsalicylic acid, acetaminophen, aspirin, and caffeine. There have not been clinical trials that evaluate the clinical efficacy of butalbital in migraines [A177754] thus it is not indicated for such condition. As with other barbiturates, butalbital carries a risk of abuse or misuse potential, intoxication, hangover, tolerance, dependence, and overdosage possibly leading to death.[L10370] Butalbital‐containing analgesics can also produce a drug‐induced headache in addition to tolerance and dependence. Due to these risks, the use of butalbital-containing combination products is typically limited for use only in cases where other medications are deemed ineffective and such usage is advised to be carefully monitored.[A177754]

cas号

77-26-9

唯一标识码

KHS0AZ4JVK

状态

solid

组

approved,illicit,

指示

Indicated for the management of the symptom complex of tension (or muscle contraction) headache, when other non-opioid analgesics and alternative treatments are inadequate, in various combinations with acetaminophen, aspirin, caffeine, and codeine .[L10370]

药效学

Butalbital is a short to intermediate-acting barbiturate that reversibly depresses the activity of excitable tissues, including the central nervous system in a nonselective manner.[A177754] Barbiturates exhibit muscle-relaxing and anti-anxiety properties [A177763] and they are capable of producing all levels of CNS mood alteration from excitation to mild sedation, hypnosis, and deep coma.[F4561] The sedative dose of butalbital in nontolerant individuals is 5-100 mg and the hypnotic dose is 100-200 mg.[T598] Pain perception and reaction are relatively unimpaired until the moment of unconsciousness.[A177754] In some cases, an unwanted paradoxical response of excitement may be observed instead of sedation with barbiturate treatment, which may be due to their depressant effects on inhibitory centers of the CNS.[A177754] At sufficiently high therapeutic doses, barbiturates induce anesthesia; however, barbiturates are reported to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks.[F4561] Barbiturates are habit-forming; they can produce tolerance and both dependence and addiction, which is partly explained by decreased drug concentration at the site of action due to enhanced drug metabolism by induced enzymes, or to cellular adaptive changes. In addition, butalbital may lead to analgesic overuse headache.[A177754] While butalbital is expected to mediate similar actions as other members of the barbiturate drug class, the effects of butalbital in isolation are not well understood.[A177763] It is suggested that butalbital is added in combination products to antagonize the unwanted central stimulating effect of stimulatory ingredients such as caffeine.[A177763] Butalbital may decrease blood pressure and heart rate when administered at sedative and hypnotic doses.[L10370]

作用机制

Butalbital is a CNS depressant that suppresses neuronal excitability, impulse conduction, and the release of neurotransmitters, similar to actions of other barbiturates.[T598] Barbiturates primarily mediate suppressive actions on polysynaptic neuronal responses by diminishing facilitation while enhancing inhibition.[A177754] Inhibition occurs at GABAergic synapses that express GABA-A receptors, which are transmembrane chloride ion channels that bind an inhibitory neurotransmitter GABA, barbiturates, benzodiazepines, neurosteroids, and ethanol.[A177754] Upon activation, GABA-A receptors allow Cl- influx and K+ efflux into the postjunctional terminal, resulting in inhibition of the postsynaptic neuron. It is suggested that barbiturates, including butalbital, enhances GABA binding to the GABA-A receptors [F4561] by binding to the α+/β− interface in the intracellular domain (ICD) as an allosteric modulator.[A177829] Additionally, barbiturates promote benzodiazepine binding to the receptor.[A177754] Barbiturates potentiate GABA-induced increases in chloride conductance and depress voltage-activated calcium currents while prolonging the duration of GABA-induced chloride channel opening.[A177754] Butalbital may also inhibit the excitatory effects mediated by AMPA receptors by reducing glutamate-induced depolarizations of the receptor. It is also proposed that barbiturates and opioids may potentiate the analgesic effects of each other when co-administered, although there are inconsistencies across preclinical data.[A177754]

毒性

Reported oral TDLO (woman) is 400 mg/kg and subcutaneous LD50 in rat is 160 mg/kg.[MSDS] The lowest acute dose of butalbital alone associated with death in adults is 2.0 g.[A177754] Symptoms of acute barbiturate poisoning include drowsiness, confusion, coma, respiratory depression, hypotension, and shock. Due to the CNS depressant effects, an overdose of barbiturates may lead to death.[L10370] Barbiturates are also associated with withdrawal reactions, which may lead to death if severe.[A177754]

代谢

Butalbital is expected to undergo nearly complete hepatic metabolism.[A177754] It primarily undergoes C5 oxidation to form 5-isobutyl-5-(2,3-dihydroxypropyl) barbituric acid, which is the major metabolite. Butalbital may also undergo omega-hydroxylation to form 5-allyl-5(3-hydroxy-2-methyl-1-propyl) barbituric acid.[A177835, L10370, T598]

吸收

Butalbital gets readily and rapidly absorbed from the gastrointestinal tract.[F4561] The time to reach the peak plasma concentrations is reported to be approximately 2 hours.[A177754] Typical blood concentrations of butalbital peaked at 2.1 mg/L and declined to 1.5 mg/L at 24 hr.[A177838] Plasma concentrations of 10 to 20 μg/mL have been associated with toxicity; coma and fatalities have occurred with concentrations of 25 to 30 μg/mL.[A177754]

半衰期

The plasma half-life is about 35 hours. In a study of 5 healthy volunteers receiving 100 mg butalbital in combination with aspirin and caffeine, the mean plasma elimination half-life of butalbital was 61 hours, with the range of 35 to 88 hours.[A177838, T598]

分类

description:This compound belongs to the class of organic compounds known as barbituric acid derivatives. These are compounds containing a perhydropyrimidine ring substituted at C-2, -4 and -6 by oxo groups.
direct-parent:Barbituric acid derivatives
kingdom:Organic compounds
superclass:Organoheterocyclic compounds
class:Diazines
subclass:Pyrimidines and pyrimidine derivatives
alternative-parent:Azacyclic compounds
alternative-parent:Carbonyl compounds
alternative-parent:Diazinanes
alternative-parent:Dicarboximides
alternative-parent:Hydrocarbon derivatives
alternative-parent:N-acyl ureas
alternative-parent:Organic oxides
alternative-parent:Organonitrogen compounds
alternative-parent:Organopnictogen compounds
substituent:1,3-diazinane
substituent:Aliphatic heteromonocyclic compound
substituent:Azacycle
substituent:Barbiturate
substituent:Carbonic acid derivative
substituent:Carbonyl group
substituent:Carboxylic acid derivative
substituent:Dicarboximide
substituent:Hydrocarbon derivative
substituent:N-acyl urea
substituent:Organic nitrogen compound
substituent:Organic oxide
substituent:Organic oxygen compound
substituent:Organonitrogen compound
substituent:Organooxygen compound
substituent:Organopnictogen compound
substituent:Urea
substituent:Ureide

消除途径

Butalbital predominantly undergoes renal elimination with 59 to 88% of the total dose administered being excreted from the kidneys as unchanged parent drug or metabolites.[L6121,L10370] Urinary excretion products included parent drug (about 3.6% of the dose), 5-isobutyl-5-(2,3-dihydroxypropyl) barbituric acid (about 24% of the dose), 5-allyl-5(3-hydroxy-2-methyl-1-propyl) barbituric acid (about 4.8%), products with the barbituric acid ring hydrolyzed with excretion of urea (about 14% of the dose), as well as unidentified materials.[L10370] Of the material excreted in the urine, 32% is conjugated.[L10370] Elimination is not complete within 24 hours, and the drug accumulates with frequent administration.[A177754]

种类

Anticholinergic Agents
D018680
Anticonvulsants
D000927
Barbiturates
D001463
Central Nervous System Depressants
D002492
Cytochrome P-450 CYP3A Inducers
D065701
Cytochrome P-450 CYP3A4 Inducers
D065701
Cytochrome P-450 CYP3A4 Inducers (strength unknown)

Cytochrome P-450 Enzyme Inducers
D065693
Hypnotics and Sedatives
D006993
Methemoglobinemia Associated Agents

Nervous System
D009420
Nicotinic Antagonists
D018733
Psycholeptics

Pyrimidines
D011743
Pyrimidinones
D011744

盐类

DBSALT002235Butalbital sodiumBBH31P2ABJ23554-70-3LIZXGILRVOONMO-UHFFFAOYSA-M246.242246.09803663

蛋白质结合

The _in vitro_ plasma protein binding of butalbital is 45% over the concentration range of 0.5-20 mcg/mL. This falls within the range of plasma protein binding (20%-45%) reported with other barbiturates such as phenobarbital, pentobarbital, and secobarbital sodium.[L10370]

清除

There is limited data on the clearance of butalbital.

同义词

language:english; code:; name;5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
language:english; code:; name;5-allyl-5-(2-methylpropyl)barbituric acid
language:english; code:; name;5-allyl-5-(2'-methyl-n-propyl) barbituric acid
language:english; code:; name;5-allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione
language:english; code:; name;5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione
language:english; code:; name;5-allyl-5-isobutylbarbituric acid
language:english; code:; name;5-isobutyl-5-allylbarbituric acid
language:english; code:; name;Allylbarbital
language:english; code:; name;Allylbarbitone
language:english; code:; name;Allylbarbituric acid
language:english; code:; name;Butalbarbital
language:english; code:inn/usan; name;Butalbital
language:latin; code:inn; name;Butalbitalum
language:english; code:; name;iso-butylallylbarbituric acid
language:english; code:; name;Itobarbital
language:english; code:; name;Tetrallobarbital

国际品牌

SandoptalSandoz Pharmaceuticals Corporations

配送量

The volume of distribution of butalbital is reported to be approximately 0.8 L/kg.[T598] Butalbital is expected to distribute to most of the tissues in the body [F4561], including the mamillary glands and placenta.[F4561] The plasma-to-blood concentration ratio was almost unity indicating that there is no preferential distribution of butalbital into either plasma or blood cells.[L10370]

产品

name:Acetaminophen, Butalbital and Caffeine
labeller:Stat Rx USA
ndc-id:
ndc-product-code:16590-022
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1988-02-16
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089536
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Alagesic LQ
labeller:Poly Pharmaceuticals
ndc-id:
ndc-product-code:50991-514
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-15
ended-marketing-on:2015-02-06
dosage-form:Syrup
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Allzital
labeller:Keswick Labs, Llc
ndc-id:
ndc-product-code:70538-450
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-12-04
ended-marketing-on:2017-03-13
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Allzital
labeller:Skylar Laboratories, Llc
ndc-id:
ndc-product-code:70362-722
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-12-04
ended-marketing-on:2020-12-06
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Allzital
labeller:Phlight Pharma, Llc
ndc-id:
ndc-product-code:70569-150
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-10-16
ended-marketing-on:2020-12-07
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Allzital
labeller:Larken Laboratories, Inc.
ndc-id:
ndc-product-code:68047-752
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-12-04
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Ascomp with Codeine
labeller:Breckenridge Pharmaceutical, Inc.
ndc-id:
ndc-product-code:51991-074
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-05-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA075231
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Ascomp with Codeine
labeller:Nexgen Pharma, Inc.
ndc-id:
ndc-product-code:0722-6094
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2001-11-30
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA075231
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Ascomp with Codeine
labeller:LGM Pharma Solutions, LLC
ndc-id:
ndc-product-code:79739-6094
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2001-11-30
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA075231
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Bupap
labeller:ECR Pharmaceuticals Co., Inc.
ndc-id:
ndc-product-code:0095-0240
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1994-12-01
ended-marketing-on:2013-07-15
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089988
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Bupap
labeller:Bausch Health US, LLC
ndc-id:
ndc-product-code:0095-3000
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-06-24
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA090956
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbita,Acetaminophen and Caffeine
labeller:Granules Pharmaceuticals Inc.
ndc-id:
ndc-product-code:70010-044
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-05-05
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA213321
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital Acetaminophen and Caffeine
labeller:Northwind Pharmaceuticals
ndc-id:
ndc-product-code:51655-590
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-05-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital Acetaminophen and Caffeine
labeller:Lake Erie Medical DBA Quality Care Products LLC
ndc-id:
ndc-product-code:49999-151
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-10-11
ended-marketing-on:2019-10-11
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA088616
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-5766
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-04-05
ended-marketing-on:2012-06-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089987
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Stat Rx USA
ndc-id:
ndc-product-code:42549-495
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1994-12-01
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089988
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Mikart, Inc.
ndc-id:
ndc-product-code:46672-098
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1992-10-26
ended-marketing-on:2014-01-14
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089988
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:E5 Pharma, Llc
ndc-id:
ndc-product-code:13517-109
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-09-13
ended-marketing-on:2017-01-12
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital And Acetaminophen
labeller:Skylar Laboratories, Llc
ndc-id:
ndc-product-code:70362-721
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-12-04
ended-marketing-on:2016-02-02
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital And Acetaminophen
labeller:Larken Laboratories, Inc.
ndc-id:
ndc-product-code:68047-721
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-12-04
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Larken Laboratories, Inc.
ndc-id:
ndc-product-code:68047-722
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-12-04
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Mayne Pharma
ndc-id:
ndc-product-code:51862-544
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-07-30
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA207313
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Nexgen Pharma, Inc.
ndc-id:
ndc-product-code:0722-7075
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-08-23
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA090956
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Par Pharmaceutical
ndc-id:
ndc-product-code:0603-2540
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1999-06-03
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089987
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Solubiomix
ndc-id:
ndc-product-code:69499-342
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-08-12
ended-marketing-on:2020-11-13
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA207313
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Mayne Pharma
ndc-id:
ndc-product-code:51862-538
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-02-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA207386
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Alvogen Inc.
ndc-id:
ndc-product-code:47781-644
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2019-12-03
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA207635
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Mikart, LLC
ndc-id:
ndc-product-code:46672-856
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-11-15
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA207386
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Alvogen, Inc.
ndc-id:
ndc-product-code:47781-628
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-10-09
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA205120
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Granules Pharmaceuticals Inc.
ndc-id:
ndc-product-code:70010-054
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-20
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA213115
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Alvogen, Inc.
ndc-id:
ndc-product-code:47781-535
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-02-24
ended-marketing-on:2020-05-01
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA205120
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Alvogen Inc.
ndc-id:
ndc-product-code:47781-534
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-06-06
ended-marketing-on:2020-09-01
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA207635
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Atland Pharmaceuticals, Llc
ndc-id:
ndc-product-code:71993-301
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-30
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Oceanside Pharmaceuticals
ndc-id:
ndc-product-code:68682-306
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-06-19
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA090956
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:County Line Pharmaceuticals, LLC
ndc-id:
ndc-product-code:43199-053
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-12-01
ended-marketing-on:2018-06-01
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA205120
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital And Acetaminophen
labeller:STI Pharma LLC
ndc-id:
ndc-product-code:54879-026
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-11-15
ended-marketing-on:2018-12-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA203484
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:Mikart, LLC
ndc-id:
ndc-product-code:46672-286
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-12-27
ended-marketing-on:2018-03-16
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA207313
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen
labeller:LGM Pharma Solutions, LLC
ndc-id:
ndc-product-code:79739-7075
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-08-23
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA090956
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital and Acetaminophen 50 mg/325 mg
labeller:Solubiomix
ndc-id:
ndc-product-code:69499-302
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-10-10
ended-marketing-on:2016-01-01
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089987
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital Compound
labeller:Major
ndc-id:
ndc-product-code:0904-3892
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2000-01-28
ended-marketing-on:2016-07-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Goldline Laboratories, Inc.
ndc-id:
ndc-product-code:0182-2694
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-11-24
ended-marketing-on:2010-11-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040336
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Keltman Pharmaceuticals Inc.
ndc-id:
ndc-product-code:68387-520
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-29
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040336
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Red Pharm Drug, Inc.
ndc-id:
ndc-product-code:67296-0718
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-27
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-1036
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-06-21
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:H.J. Harkins Company
ndc-id:
ndc-product-code:52959-913
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-25
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040513
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Rebel Distributors
ndc-id:
ndc-product-code:21695-257
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-12-15
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040336
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Rebel Distributors
ndc-id:
ndc-product-code:21695-843
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-12-23
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040496
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Mikart, Inc.
ndc-id:
ndc-product-code:46672-184
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-12-23
ended-marketing-on:2012-04-01
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040496
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Rebel Distributors
ndc-id:
ndc-product-code:42254-323
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-25
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040513
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Unit Dose Services
ndc-id:
ndc-product-code:50436-4856
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1987-01-21
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:A S Medication Solutions
ndc-id:
ndc-product-code:54569-2538
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-27
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Mallinckrodt
ndc-id:
ndc-product-code:0406-0970
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2008-02-28
ended-marketing-on:2009-09-02
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA087804
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Aphena Pharma Solutions Tennessee, Inc.
ndc-id:
ndc-product-code:67544-394
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-27
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Qualitest
ndc-id:
ndc-product-code:0603-2545
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-25
ended-marketing-on:2013-12-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040513
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Mikart, Inc.
ndc-id:
ndc-product-code:46672-059
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1988-05-23
ended-marketing-on:2014-01-14
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089451
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-5943
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2008-09-30
ended-marketing-on:2014-01-14
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040261
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Victory Pharmaceutical
ndc-id:
ndc-product-code:68453-170
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1998-10-28
ended-marketing-on:2013-11-22
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040261
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Lake Erie Medical Dba Quality Care Produts Llc
ndc-id:
ndc-product-code:35356-862
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-25
ended-marketing-on:2013-12-01
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040513
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Carilion Materials Management
ndc-id:
ndc-product-code:68151-1313
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-27
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Mikart, Inc.
ndc-id:
ndc-product-code:46672-228
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-03-17
ended-marketing-on:2015-07-17
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA089007
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Remedy Repack
ndc-id:
ndc-product-code:52125-276
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-10-11
ended-marketing-on:2017-01-18
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Remedy Repack
ndc-id:
ndc-product-code:52125-275
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-10-11
ended-marketing-on:2017-01-18
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Remedy Repack
ndc-id:
ndc-product-code:52125-274
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-10-11
ended-marketing-on:2017-01-18
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-0832
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-27
ended-marketing-on:2011-09-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Marlex Pharmaceuticals Inc
ndc-id:
ndc-product-code:10135-628
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-04-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA207118
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Atlantic Biologicals Corps.
ndc-id:
ndc-product-code:17856-1787
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Preferreed Pharmaceuticals Inc.
ndc-id:
ndc-product-code:68788-9025
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Preferreed Pharmaceuticals Inc.
ndc-id:
ndc-product-code:68788-9711
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-01-30
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-2073
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-09-24
ended-marketing-on:2016-03-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Aphena Pharma Solutions Tennessee, Inc.
ndc-id:
ndc-product-code:71610-042
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-01-08
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Vintage Pharmaceuticals, LLC
ndc-id:
ndc-product-code:0254-2357
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-11-08
ended-marketing-on:2006-11-08
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Vintage Pharmaceuticals, LLC
ndc-id:
ndc-product-code:0254-2355
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-11-14
ended-marketing-on:2007-11-14
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-7147
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-06-01
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Proficient Rx LP
ndc-id:
ndc-product-code:63187-520
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1987-01-21
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Mikart, LLC
ndc-id:
ndc-product-code:46672-053
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1987-01-21
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-2105
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-7988
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:PD-Rx Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:55289-879
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-27
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Mayne Pharma
ndc-id:
ndc-product-code:51862-179
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-04-16
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA089007
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Par Pharmaceutical
ndc-id:
ndc-product-code:0603-2544
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-27
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Xspire Pharma, Llc
ndc-id:
ndc-product-code:42195-955
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-08-04
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA206615
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:KVK-Tech, Inc.
ndc-id:
ndc-product-code:10702-253
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-09-26
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA211106
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Nucare Pharmaceuticals,inc.
ndc-id:
ndc-product-code:68071-4657
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-08-28
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Golden State Medical Supply
ndc-id:
ndc-product-code:60429-589
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1987-01-21
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:American Health Packaging
ndc-id:
ndc-product-code:68084-396
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-09-08
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Aurolife Pharma, LLC
ndc-id:
ndc-product-code:13107-075
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-04-26
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA204733
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Mikart, LLC
ndc-id:
ndc-product-code:46672-633
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-01-31
ended-marketing-on:
dosage-form:Syrup
strength:
route:Oral
fda-application-number:ANDA040387
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Lannett Company, Inc.
ndc-id:
ndc-product-code:0527-4094
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2019-12-17
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA212083
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:SUNRISE PHARMACEUTICAL, INC
ndc-id:
ndc-product-code:11534-187
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-01-10
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA207118
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Major Pharmaceuticals
ndc-id:
ndc-product-code:0904-6538
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:71335-0347
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1987-01-21
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Mayne Pharma
ndc-id:
ndc-product-code:51862-540
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-08-28
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Mayne Pharma
ndc-id:
ndc-product-code:51862-542
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-03-09
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA210817
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Hikma Pharmaceuticals USA Inc.
ndc-id:
ndc-product-code:0143-1787
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:2021-03-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Golden State Medical Supply
ndc-id:
ndc-product-code:51407-200
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-10-28
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA207118
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Direct Rx
ndc-id:
ndc-product-code:61919-022
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-01-01
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:PD-Rx Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:43063-369
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:2020-01-17
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:61786-365
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-07-20
ended-marketing-on:2018-01-16
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:KAISER FOUNDATION HOSPITALS
ndc-id:
ndc-product-code:0179-0137
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-08-19
ended-marketing-on:2015-09-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:AvPAK
ndc-id:
ndc-product-code:50268-139
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-07-21
ended-marketing-on:2019-03-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Nucare Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:66267-039
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1987-01-21
ended-marketing-on:2019-12-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Avera McKennan Hospital
ndc-id:
ndc-product-code:69189-2544
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-03-13
ended-marketing-on:2017-05-24
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:63629-1774
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-27
ended-marketing-on:2016-01-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040511
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Taro Pharmaceuticals U.S.A., Inc.
ndc-id:
ndc-product-code:51672-4222
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-07-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA213046
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine
labeller:Proficient Rx LP
ndc-id:
ndc-product-code:71205-962
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-08-04
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA206615
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine Plus
labeller:Stat Rx USA
ndc-id:
ndc-product-code:16590-581
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-08-25
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040513
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen and Caffeine with Codeine Phosphate
labeller:Hikma Pharmaceuticals USA Inc.
ndc-id:
ndc-product-code:0143-3000
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2001-03-21
ended-marketing-on:2015-11-10
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA075618
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Rebel Distributors
ndc-id:
ndc-product-code:21695-209
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Med Pharma Co., Ltd.
ndc-id:
ndc-product-code:51138-012
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-01-10
ended-marketing-on:2012-03-19
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040336
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Stat Rx USA
ndc-id:
ndc-product-code:42549-553
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:West Ward Pharmaceutical
ndc-id:
ndc-product-code:0143-0170
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1998-10-28
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040261
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Rxchange Co
ndc-id:
ndc-product-code:33358-059
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-11-06
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Mirror Pharmaceuticals LLC
ndc-id:
ndc-product-code:52682-041
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-08-08
ended-marketing-on:2017-09-27
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040864
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Mirror Pharmaceuticals LLC
ndc-id:
ndc-product-code:52682-026
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-08-08
ended-marketing-on:2017-09-27
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040883
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-0371
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-12-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA088616
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Nucare Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:68071-3120
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:West-Ward Pharmaceuticals Corp
ndc-id:
ndc-product-code:0143-1115
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1999-08-18
ended-marketing-on:2014-03-11
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040336
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Unit Dose Services
ndc-id:
ndc-product-code:50436-3369
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-12-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA088616
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Preferreed Pharmaceuticals Inc.
ndc-id:
ndc-product-code:68788-6939
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-03-29
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Preferreed Pharmaceuticals Inc.
ndc-id:
ndc-product-code:68788-9287
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-05-08
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA088616
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-7452
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:2012-06-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Unit Dose Services
ndc-id:
ndc-product-code:50436-1695
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Rpk Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:53002-6030
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-2564
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Nucare Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:68071-3249
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1134
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-04-25
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:0591-3369
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-12-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA088616
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Nexgen Pharma, Inc.
ndc-id:
ndc-product-code:0722-7029
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-11-16
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040885
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Nexgen Pharma, Inc.
ndc-id:
ndc-product-code:0722-7320
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-11-01
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA209587
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Lake Erie Medical DBA Quality Care Products LLC
ndc-id:
ndc-product-code:55700-662
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-07-26
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:medsource pharmaceuticals
ndc-id:
ndc-product-code:45865-352
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Major Pharmaceuticals
ndc-id:
ndc-product-code:0904-6938
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Lannett Company, Inc.
ndc-id:
ndc-product-code:0527-1695
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:AvKARE, Inc.
ndc-id:
ndc-product-code:42291-181
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-11-24
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040885
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Alvogen Inc.
ndc-id:
ndc-product-code:47781-625
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-01-30
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA204984
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Lannett Company, Inc.
ndc-id:
ndc-product-code:0527-4095
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2019-12-17
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA212082
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:71335-0365
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Proficient Rx LP
ndc-id:
ndc-product-code:63187-933
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:0591-2640
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-07-29
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040885
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Golden State Medical Supply, Inc.
ndc-id:
ndc-product-code:60429-252
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1995-06-12
ended-marketing-on:2017-01-02
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089718
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Golden State Medical Supply, Inc.
ndc-id:
ndc-product-code:60429-253
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1998-08-18
ended-marketing-on:2017-01-02
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040336
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Alvogen Inc.
ndc-id:
ndc-product-code:47781-536
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-01-30
ended-marketing-on:2020-01-01
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA204984
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:Zydus Pharmaceuticals (USA) Inc.
ndc-id:
ndc-product-code:70710-1378
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-07-21
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA211543
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:LGM Pharma Solutions, LLC
ndc-id:
ndc-product-code:79739-7320
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-11-01
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA209587
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:NorthStar Rx LLC
ndc-id:
ndc-product-code:16714-170
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-07-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA213046
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, and Caffeine
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:63629-8392
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-09-13
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA200243
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-823
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-11-15
ended-marketing-on:2012-11-18
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040513
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine
labeller:Westminster Pharmaceuticals, LLC
ndc-id:
ndc-product-code:69367-203
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2019-03-05
ended-marketing-on:
dosage-form:Tablet, coated
strength:
route:Oral
fda-application-number:ANDA209587
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine
labeller:Proficient Rx LP
ndc-id:
ndc-product-code:71205-981
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2019-03-05
ended-marketing-on:
dosage-form:Tablet, coated
strength:
route:Oral
fda-application-number:ANDA209587
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine
labeller:Proficient Rx LP
ndc-id:
ndc-product-code:71205-510
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2019-03-05
ended-marketing-on:
dosage-form:Tablet, coated
strength:
route:Oral
fda-application-number:ANDA209587
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
labeller:Dispensing Solutions, Inc.
ndc-id:
ndc-product-code:68258-2012
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-07-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA076560
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
labeller:Breckenridge Pharmaceutical, Inc.
ndc-id:
ndc-product-code:51991-073
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-07-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA076560
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:71335-0194
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-07-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA076560
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-5162
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-07-06
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA020232
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:63629-3152
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-09-18
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA020232
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:Vintage Pharmaceuticals, LLC
ndc-id:
ndc-product-code:0254-3109
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-01-22
ended-marketing-on:2007-01-22
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:Par Pharmaceutical
ndc-id:
ndc-product-code:0603-2553
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-04-22
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA075929
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:0591-3220
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-09-18
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA020232
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:0591-2641
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-07-29
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA076560
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:Nexgen Pharma, Inc.
ndc-id:
ndc-product-code:0722-6670
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-06-10
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA076560
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:Nexgen Pharma, Inc.
ndc-id:
ndc-product-code:0722-7028
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-06-10
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA076560
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:71335-0653
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-04-22
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA075929
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:LGM Pharma Solutions, LLC
ndc-id:
ndc-product-code:79739-7028
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-06-10
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA076560
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
labeller:LGM Pharma Solutions LLC
ndc-id:
ndc-product-code:79739-6670
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-06-10
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA076560
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetominophen and Caffeine
labeller:Rising Pharmaceuticals
ndc-id:
ndc-product-code:64980-154
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-07-08
ended-marketing-on:2010-07-12
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040864
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetominophen and Caffeine
labeller:Rising Pharmaceuticals
ndc-id:
ndc-product-code:64980-155
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-04-27
ended-marketing-on:2010-07-12
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040883
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Acetominophen and Caffeine
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:63629-4099
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-04-27
ended-marketing-on:2017-12-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040883
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:Rebel Distributors
ndc-id:
ndc-product-code:21695-354
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-12-15
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:Goldline Laboratories, Inc.
ndc-id:
ndc-product-code:0182-1631
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:2011-07-01
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:Dispensing Solutions, Inc.
ndc-id:
ndc-product-code:66336-619
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1979-06-05
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:H.J. Harkins Company
ndc-id:
ndc-product-code:52959-370
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1979-06-05
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:A S Medication Solutions
ndc-id:
ndc-product-code:54569-0339
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1979-06-05
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-1075
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1998-03-09
ended-marketing-on:2013-11-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:Qualitest
ndc-id:
ndc-product-code:0603-2548
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1979-06-05
ended-marketing-on:2012-07-17
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:Lake Erie Medical &Surgical Supply Dba Quality Care Products Llc
ndc-id:
ndc-product-code:49999-115
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-02-23
ended-marketing-on:2015-12-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:PD-Rx Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:55289-040
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1979-06-05
ended-marketing-on:2018-08-01
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:Vensun Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:42543-098
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-06-22
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA204195
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:63629-2951
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1979-06-05
ended-marketing-on:2016-07-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin and Caffeine
labeller:Hikma Pharmaceuticals USA Inc.
ndc-id:
ndc-product-code:0143-1785
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1979-06-05
ended-marketing-on:2016-09-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086162
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:Mutual Pharmaceutical
ndc-id:
ndc-product-code:53489-622
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-06-13
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:Stat Rx USA
ndc-id:
ndc-product-code:16590-911
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1976-05-04
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:Rebel Distributors
ndc-id:
ndc-product-code:21695-139
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-09-18
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA086231
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:Aidarex Pharmaceuticals LLC
ndc-id:
ndc-product-code:33261-922
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1976-05-04
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:A S Medication Solutions
ndc-id:
ndc-product-code:54569-6554
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-10-06
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:A S Medication Solutions
ndc-id:
ndc-product-code:54569-8372
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-10-06
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:Amerincan Health Packaging
ndc-id:
ndc-product-code:68084-934
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-03-31
ended-marketing-on:2018-09-30
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, aspirin, and caffeine
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-1579
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1985-10-11
ended-marketing-on:2017-07-31
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA086996
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-1464
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-10-06
ended-marketing-on:2016-01-31
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:Actavis Pharma Company
ndc-id:
ndc-product-code:0228-2023
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1990-09-30
ended-marketing-on:2011-02-28
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA086710
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:0591-3219
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-10-06
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, aspirin, and caffeine
labeller:Lannett Company, Inc.
ndc-id:
ndc-product-code:0527-1552
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1985-10-11
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA086996
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, aspirin, and caffeine
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-1580
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1985-10-11
ended-marketing-on:2019-05-31
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA086996
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, and Caffeine
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-1465
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-10-06
ended-marketing-on:2018-01-10
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, aspirin, and caffeine
labeller:Lake Erie Medical DBA Quality Care Products LLC
ndc-id:
ndc-product-code:55700-129
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1985-10-11
ended-marketing-on:2019-10-11
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA086996
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
labeller:Jerome Stevens Pharmaceuticals
ndc-id:
ndc-product-code:50564-507
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-10-25
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-1037
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1998-06-02
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA074359
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
labeller:A S Medication Solutions
ndc-id:
ndc-product-code:54569-0337
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-10-26
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA019429
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-0103
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-10-26
ended-marketing-on:2017-08-31
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA019429
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:63629-2952
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-05-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA075231
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
labeller:Amneal Pharmaceuticals NY LLC
ndc-id:
ndc-product-code:69238-1993
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2019-04-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA074951
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:0591-3546
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-10-26
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA019429
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
labeller:Lannett Company, Inc.
ndc-id:
ndc-product-code:0527-1312
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1998-08-31
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA074951
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine, and Codeine Phosphate
labeller:Endo Pharmaceuticals Inc.
ndc-id:
ndc-product-code:60951-675
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-09-19
ended-marketing-on:2006-09-19
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine, and Codeine Phosphate
labeller:Watson Laboratories, Inc.
ndc-id:
ndc-product-code:0591-0425
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-02-17
ended-marketing-on:2007-02-17
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butalbital, Aspirin, Caffeine, and Codeine Phosphate
labeller:Mayne Pharma Inc.
ndc-id:
ndc-product-code:68308-312
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-10-30
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA203335
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Butapap
labeller:Mikart, LLC
ndc-id:
ndc-product-code:46672-099
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1992-10-26
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089987
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Capacet
labeller:Magna Pharmaceuticals
ndc-id:
ndc-product-code:58407-534
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-05-02
ended-marketing-on:2017-12-31
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA089007
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Dolgic Plus
labeller:Shionogi
ndc-id:
ndc-product-code:59630-074
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-10-10
ended-marketing-on:2015-01-03
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA040496
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Esgic
labeller:Forest Laboratories
ndc-id:
ndc-product-code:0535-0011
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1997-06-01
ended-marketing-on:2015-02-27
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Esgic
labeller:Forest Laboratories
ndc-id:
ndc-product-code:0535-0012
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1997-04-09
ended-marketing-on:2016-08-28
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA089007
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Esgic
labeller:Mayne Pharma Inc.
ndc-id:
ndc-product-code:68308-219
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-05-01
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA089007
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Esgic
labeller:Mayne Pharma Inc.
ndc-id:
ndc-product-code:68308-220
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-05-01
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089175
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Esgic-Plus
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-2778
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1997-10-10
ended-marketing-on:2010-06-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089451
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Esgic-Plus
labeller:A S Medication Solutions
ndc-id:
ndc-product-code:54569-3441
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1997-10-10
ended-marketing-on:2014-06-29
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089451
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Esgic-Plus
labeller:Forest Laboratories
ndc-id:
ndc-product-code:0456-0679
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-08-13
ended-marketing-on:2015-08-10
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040085
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Esgic-Plus
labeller:Forest Laboratories
ndc-id:
ndc-product-code:0456-0678
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1997-10-10
ended-marketing-on:2014-06-29
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089451
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fioricet
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-1053
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2001-02-15
ended-marketing-on:2011-06-30
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA088616
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fioricet
labeller:Actavis Pharma Company
ndc-id:
ndc-product-code:52544-957
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1984-11-09
ended-marketing-on:2013-07-26
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA088616
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fioricet
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:52544-080
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-07-29
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040885
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fioricet
labeller:McKesson Corporation dba RX Pak
ndc-id:
ndc-product-code:65084-454
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-07-29
ended-marketing-on:2019-09-01
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040885
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fioricet
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-3416
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1984-11-09
ended-marketing-on:2013-07-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA088616
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fioricet with Codeine
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-3317
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1994-05-24
ended-marketing-on:2011-06-30
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA020232
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fioricet with Codeine
labeller:Actavis Pharma Company
ndc-id:
ndc-product-code:52544-958
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1992-07-30
ended-marketing-on:2013-07-26
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA020232
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fioricet with Codeine
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:52544-082
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-07-29
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA076560
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fiorinal
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-1031
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1976-05-04
ended-marketing-on:2011-06-30
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fiorinal
labeller:Allergan, Inc.
ndc-id:
ndc-product-code:0023-6146
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1976-05-04
ended-marketing-on:2022-06-30
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fiorinal
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:52544-955
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1976-05-04
ended-marketing-on:2020-01-31
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA017534
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fiorinal
labeller:Aralez Pharmaceuticals Canada Inc
ndc-id:
ndc-product-code:
dpd-id:00226327
ema-product-code:
ema-ma-number:
started-marketing-on:1971-12-31
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Fiorinal Tab
labeller:Novartis
ndc-id:
ndc-product-code:
dpd-id:00275328
ema-product-code:
ema-ma-number:
started-marketing-on:1973-12-31
ended-marketing-on:2009-08-20
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Fiorinal with Codeine
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-0530
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1990-10-26
ended-marketing-on:2011-06-30
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA019429
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fiorinal with Codeine
labeller:Actavis Pharma, Inc.
ndc-id:
ndc-product-code:52544-956
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1990-10-26
ended-marketing-on:2020-03-31
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA019429
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fiorinal with Codeine
labeller:Allergan, Inc.
ndc-id:
ndc-product-code:0023-6010
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1990-10-26
ended-marketing-on:2022-04-30
dosage-form:Capsule
strength:
route:Oral
fda-application-number:NDA019429
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Fiorinal-C 1/2
labeller:Aralez Pharmaceuticals Canada Inc
ndc-id:
ndc-product-code:
dpd-id:00176206
ema-product-code:
ema-ma-number:
started-marketing-on:1970-12-31
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Fiorinal-C 1/4
labeller:Aralez Pharmaceuticals Canada Inc
ndc-id:
ndc-product-code:
dpd-id:00176192
ema-product-code:
ema-ma-number:
started-marketing-on:1970-12-31
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Margesic
labeller:Marnel Pharmaceuticals, Llc
ndc-id:
ndc-product-code:0682-0804
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1994-06-01
ended-marketing-on:2018-05-01
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA089007
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Marten-Tab
labeller:Marnel Pharmaceuticals, Llc
ndc-id:
ndc-product-code:0682-1400
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-01-11
ended-marketing-on:2017-12-17
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089987
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Orbivan
labeller:Atley Pharmaceuticals
ndc-id:
ndc-product-code:59702-661
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-04-23
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040885
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Orbivan
labeller:ECR Pharmaceuticals Co., Inc.
ndc-id:
ndc-product-code:0095-7029
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-08-21
ended-marketing-on:2013-07-17
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040885
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Orbivan CF
labeller:ECR Pharmaceuticals Co., Inc.
ndc-id:
ndc-product-code:0095-7075
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-03-08
ended-marketing-on:2013-07-17
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA090956
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Phrenilin
labeller:Valeant Pharmaceuticals North America
ndc-id:
ndc-product-code:0187-0843
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2005-09-05
ended-marketing-on:2007-09-30
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA074911
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Phrenilin
labeller:Valeant Pharmaceuticals North America
ndc-id:
ndc-product-code:0187-0842
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-05-03
ended-marketing-on:2013-12-31
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA087811
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Phrenilin Forte
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-1109
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-05-03
ended-marketing-on:2012-06-30
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA088831
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Phrenilin Forte
labeller:Valeant Pharmaceuticals North America
ndc-id:
ndc-product-code:0187-0844
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-05-03
ended-marketing-on:2016-09-30
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA088831
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Phrenilin Forte
labeller:Wraser Llc
ndc-id:
ndc-product-code:66992-955
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-09-18
ended-marketing-on:2019-10-22
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA206615
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PMS-pharnal Capsules
labeller:Pharmascience Inc
ndc-id:
ndc-product-code:
dpd-id:02232988
ema-product-code:
ema-ma-number:
started-marketing-on:
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:PMS-pharnal Tablets
labeller:Pharmascience Inc
ndc-id:
ndc-product-code:
dpd-id:02232989
ema-product-code:
ema-ma-number:
started-marketing-on:
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:PMS-pharnal-C 1/4 Capsules
labeller:Pharmascience Inc
ndc-id:
ndc-product-code:
dpd-id:02232985
ema-product-code:
ema-ma-number:
started-marketing-on:
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:PMS-pharnal-C1/2 Capsules
labeller:Pharmascience Inc
ndc-id:
ndc-product-code:
dpd-id:02232986
ema-product-code:
ema-ma-number:
started-marketing-on:
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Pronal - C1/2 Capsules
labeller:Pro Doc Limitee
ndc-id:
ndc-product-code:
dpd-id:02229734
ema-product-code:
ema-ma-number:
started-marketing-on:2009-06-25
ended-marketing-on:2013-01-18
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Pronal C1/4 Capsules
labeller:Pro Doc Limitee
ndc-id:
ndc-product-code:
dpd-id:02229735
ema-product-code:
ema-ma-number:
started-marketing-on:2009-06-25
ended-marketing-on:2013-01-18
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Pronal Capsules
labeller:Pro Doc Limitee
ndc-id:
ndc-product-code:
dpd-id:02229733
ema-product-code:
ema-ma-number:
started-marketing-on:2009-06-23
ended-marketing-on:2012-07-23
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Pronal Tablets
labeller:Pro Doc Limitee
ndc-id:
ndc-product-code:
dpd-id:02229736
ema-product-code:
ema-ma-number:
started-marketing-on:2009-06-25
ended-marketing-on:2017-11-22
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Tencon
labeller:International Ethical Labs.
ndc-id:
ndc-product-code:11584-0029
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2001-11-30
ended-marketing-on:2015-10-02
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089988
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Tencon
labeller:International Ethical Labs, Inc.
ndc-id:
ndc-product-code:11584-0030
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-10-10
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:ANDA089987
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Teva-tecnal
labeller:TEVA Canada Limited
ndc-id:
ndc-product-code:
dpd-id:00608211
ema-product-code:
ema-ma-number:
started-marketing-on:1984-12-31
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Teva-tecnal
labeller:TEVA Canada Limited
ndc-id:
ndc-product-code:
dpd-id:00608238
ema-product-code:
ema-ma-number:
started-marketing-on:1985-12-31
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Teva-tecnal C 1/2
labeller:TEVA Canada Limited
ndc-id:
ndc-product-code:
dpd-id:00608181
ema-product-code:
ema-ma-number:
started-marketing-on:1984-12-31
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Teva-tecnal C 1/4
labeller:TEVA Canada Limited
ndc-id:
ndc-product-code:
dpd-id:00608203
ema-product-code:
ema-ma-number:
started-marketing-on:1984-12-31
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Trianal C½
labeller:Laboratoire Riva Inc.
ndc-id:
ndc-product-code:
dpd-id:01971387
ema-product-code:
ema-ma-number:
started-marketing-on:1998-03-09
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Trianal C¼
labeller:Laboratoire Riva Inc.
ndc-id:
ndc-product-code:
dpd-id:02242406
ema-product-code:
ema-ma-number:
started-marketing-on:2006-12-22
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Trianal Capsules
labeller:Laboratoire Riva Inc
ndc-id:
ndc-product-code:
dpd-id:01971417
ema-product-code:
ema-ma-number:
started-marketing-on:1997-06-02
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Trianal Tablet
labeller:Laboratoire Riva Inc
ndc-id:
ndc-product-code:
dpd-id:01971409
ema-product-code:
ema-ma-number:
started-marketing-on:1997-02-07
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Vanatol LQ
labeller:Gm Pharmaceuticals
ndc-id:
ndc-product-code:58809-820
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-04-28
ended-marketing-on:
dosage-form:Syrup
strength:
route:Oral
fda-application-number:ANDA040387
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Vanatol S
labeller:Gm Pharmaceuticals
ndc-id:
ndc-product-code:58809-359
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-07-01
ended-marketing-on:
dosage-form:Syrup
strength:
route:Oral
fda-application-number:ANDA040387
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Vtol LQ
labeller:Monarch PCM, LLC
ndc-id:
ndc-product-code:70154-111
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2019-11-11
ended-marketing-on:
dosage-form:Syrup
strength:
route:Oral
fda-application-number:ANDA040387
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Zebutal
labeller:Shionogi
ndc-id:
ndc-product-code:59630-170
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1998-10-28
ended-marketing-on:2013-11-22
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA040261
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Zebutal
labeller:Mayne Pharma Inc.
ndc-id:
ndc-product-code:68308-554
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-12-26
ended-marketing-on:
dosage-form:Capsule
strength:
route:Oral
fda-application-number:ANDA089007
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC

混合物

name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Orbivan
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine Plus
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Acetaminophen, Butalbital and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Fioricet with Codeine
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Fioricet
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Fiorinal with Codeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Fiorinal
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Orbivan
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Esgic-Plus
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Esgic-Plus
ingredients:Acetaminophen + Butalbital + Caffeine
name:Bupap
ingredients:Acetaminophen + Butalbital
name:Esgic-Plus
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Esgic-Plus
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Phrenilin Forte
ingredients:Acetaminophen + Butalbital
name:Orbivan CF
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Phrenilin
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Dolgic Plus
ingredients:Acetaminophen + Butalbital + Caffeine
name:Alagesic LQ
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Phrenilin
ingredients:Acetaminophen + Butalbital
name:Phrenilin Forte
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetominophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetominophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Esgic
ingredients:Acetaminophen + Butalbital + Caffeine
name:Fioricet
ingredients:Acetaminophen + Butalbital + Caffeine
name:Fioricet with Codeine
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Tencon
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Zebutal
ingredients:Acetaminophen + Butalbital + Caffeine
name:Esgic
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen 50 mg/325 mg
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital Compound
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Allzital
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, aspirin, and caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Capacet
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Marten-Tab
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Fiorinal
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Aspirin, Caffeine, and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Aspirin, Caffeine, and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital And Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Fiorinal
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Fiorinal with Codeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Aspirin, Caffeine, and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital And Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Allzital
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Esgic
ingredients:Acetaminophen + Butalbital + Caffeine
name:Zebutal
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Ascomp with Codeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Vanatol LQ
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Esgic
ingredients:Acetaminophen + Butalbital + Caffeine
name:Vanatol S
ingredients:Acetaminophen + Butalbital + Caffeine
name:Vtol LQ
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, aspirin, and caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Allzital
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butapap
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, Caffeine and Codeine Phosphate
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Ascomp with Codeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Fioricet with Codeine
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Tencon
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbita,Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Bupap
ingredients:Acetaminophen + Butalbital
name:Fioricet
ingredients:Acetaminophen + Butalbital + Caffeine
name:Margesic
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, aspirin, and caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine with Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetominophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin, and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Phrenilin Forte
ingredients:Acetaminophen + Butalbital + Caffeine
name:Fioricet
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, aspirin, and caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital And Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Fioricet
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Aspirin and Caffeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Fiorinal with Codeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
ingredients:Acetaminophen + Butalbital + Caffeine + Codeine
name:Butalbital and Acetaminophen
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Ascomp with Codeine
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Allzital
ingredients:Acetaminophen + Butalbital
name:Butalbital, Acetaminophen and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Butalbital, Acetaminophen, and Caffeine
ingredients:Acetaminophen + Butalbital + Caffeine
name:Pronal - C1/2 Capsules
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Fiorinal-C 1/4
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Fiorinal-C 1/2
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Trianal Tablet
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Trianal Capsules
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:PMS-pharnal-C 1/4 Capsules
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:PMS-pharnal-C1/2 Capsules
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:PMS-pharnal Capsules
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:PMS-pharnal Tablets
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Teva-tecnal
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Teva-tecnal C 1/2
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Trianal C½
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Trianal C¼
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Pronal Tablets
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Teva-tecnal C 1/4
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Teva-tecnal
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Fiorinal Tab
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Pronal Capsules
ingredients:Acetylsalicylic acid + Butalbital + Caffeine
name:Pronal C1/4 Capsules
ingredients:Acetylsalicylic acid + Butalbital + Caffeine + Codeine
name:Fiorinal
ingredients:Acetylsalicylic acid + Butalbital + Caffeine

包装者

name:Atley Pharmaceuticals
url:http://www.atley.com
name:Cardinal Health
url:http://www.cardinal.com
name:Chattem Chemicals Inc.
url:http://www.chattem.com
name:D.M. Graham Laboratories Inc.
url:
name:Diversified Healthcare Services Inc.
url:http://www.dhscorp.com
name:ECR Pharmaceuticals
url:http://www.ecrpharma.com
name:Everett Laboratories Inc.
url:http://www.everettlabs.com
name:Innoviant Pharmacy Inc.
url:http://www.innoviantpharmacy.com
name:International Ethical Labs Inc.
url:http://www.intetlab.com
name:Ivax Pharmaceuticals
url:
name:Marnel Pharmaceuticals Inc.
url:
name:MCR American Pharmaceuticals Inc.
url:http://www.mcramerican.com
name:Medisca Inc.
url:http://www.medisca.com
name:Merz Pharmaceuticals LLC
url:http://www.merz.com
name:Mikart Inc.
url:http://www.mikart.com
name:Nucare Pharmaceuticals Inc.
url:http://www.nucarerx.com
name:PD-Rx Pharmaceuticals Inc.
url:http://www.pdrx.com
name:Physicians Total Care Inc.
url:http://www.physicianstotalcare.com
name:Qualitest
url:http://www.worldoftest.com
name:Savage Labs
url:http://www.savagelabs.com
name:Southwood Pharmaceuticals
url:http://www.southwoodhealthcare.com
name:Stat Rx Usa
url:http://statrxusa.exporterus.com
name:Va Cmop Dallas
url:
name:Valeant Ltd.
url:http://www.valeant.com
name:West-Ward Pharmaceuticals
url:http://www.west-ward.com

生产者

价格

Butalbital compound tablet
1.04(单位：USD）
tablet
Butalbital powder
3.83(单位：USD）
g

受影响的生物体

Humans and other mammals

剂量

form:Syrup
route:Oral
strength:
form:Tablet, coated
route:Oral
strength:
form:Tablet
route:Oral
strength:
form:Capsule
route:Oral
strength:
form:Suppository
route:Rectal
strength:150 mg
form:Tablet, coated
route:Oral
strength:50 mg

atc代码

Barbiturates, combinations
HYPNOTICS AND SEDATIVES
PSYCHOLEPTICS
NERVOUS SYSTEM

fda标签

化学品安全技术说明书

//s3-us-west-2.amazonaws.com/drugbank/msds/DB00241.pdf?1556642744

专利

食物相互作用

Avoid alcohol. Profound CNS depression can occur.

药物相互作用

DB01238
The metabolism of Aripiprazole can be increased when combined with Butalbital.
DB14185
The metabolism of Aripiprazole lauroxil can be increased when combined with Butalbital.
DB00921
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
DB00366
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00470
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00450
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00956
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
DB00557
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00653
The therapeutic efficacy of Butalbital can be increased when used in combination with Magnesium sulfate.
DB01403
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
DB00765
Butalbital may increase the sedative activities of Metyrosine.
DB01017
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00370
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
DB00486
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB01173
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
DB09117
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
DB00413
Butalbital may increase the sedative activities of Pramipexole.
DB00268
Butalbital may increase the sedative activities of Ropinirole.
DB05271
Butalbital may increase the sedative activities of Rotigotine.
DB06201
The risk or severity of adverse effects can be increased when Rufinamide is combined with Butalbital.
DB09034
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
DB06204
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB01041
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
DB00425
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
DB09527
The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Butalbital.
DB00358
The therapeutic efficacy of Butalbital can be decreased when used in combination with Mefloquine.
DB01083
Orlistat can cause a decrease in the absorption of Butalbital resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB09288
The metabolism of Propacetamol can be increased when combined with Butalbital.
DB00446
The metabolism of Butalbital can be decreased when combined with Chloramphenicol.
DB00254
The serum concentration of Doxycycline can be decreased when it is combined with Butalbital.
DB00949
The serum concentration of Butalbital can be increased when it is combined with Felbamate.
DB00400
The serum concentration of Griseofulvin can be decreased when it is combined with Butalbital.
DB00555
The serum concentration of Lamotrigine can be decreased when it is combined with Butalbital.
DB06148
Mianserin may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00794
The risk or severity of adverse effects can be increased when Primidone is combined with Butalbital.
DB00849
The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Butalbital.
DB00165
The metabolism of Butalbital can be increased when combined with Pyridoxine.
DB00444
The serum concentration of Teniposide can be decreased when it is combined with Butalbital.
DB08867
The serum concentration of Ulipristal can be decreased when it is combined with Butalbital.
DB00582
The serum concentration of Voriconazole can be decreased when it is combined with Butalbital.
DB00750
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Prilocaine.
DB01030
Butalbital may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.
DB00333
The risk or severity of adverse effects can be increased when Methadone is combined with Butalbital.
DB09072
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
DB01181
The metabolism of Ifosfamide can be increased when combined with Butalbital.
DB08883
The metabolism of Perampanel can be increased when combined with Butalbital.
DB00682
The metabolism of Warfarin can be increased when combined with Butalbital.
DB01418
The metabolism of Acenocoumarol can be increased when combined with Butalbital.
DB08496
The metabolism of (R)-warfarin can be increased when combined with Butalbital.
DB08735
The metabolism of R,S-Warfarin alcohol can be increased when combined with Butalbital.
DB08736
The metabolism of S,R-Warfarin alcohol can be increased when combined with Butalbital.
DB14055
The metabolism of (S)-Warfarin can be increased when combined with Butalbital.
DB01284
The risk or severity of liver damage can be increased when Tetracosactide is combined with Butalbital.
DB01223
The therapeutic efficacy of Butalbital can be decreased when used in combination with Aminophylline.
DB00083
The risk or severity of adverse effects can be increased when Butalbital is combined with Botulinum toxin type A.
DB00042
The risk or severity of adverse effects can be increased when Butalbital is combined with Botulinum Toxin Type B.
DB00454
Butalbital may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Meperidine.
DB09099
The risk or severity of adverse effects can be increased when Somatostatin is combined with Butalbital.
DB00898
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
DB00972
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
DB00484
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00176
The risk or severity of adverse effects can be increased when Butalbital is combined with Fluvoxamine.
DB00215
The risk or severity of adverse effects can be increased when Butalbital is combined with Citalopram.
DB00476
The risk or severity of adverse effects can be increased when Butalbital is combined with Duloxetine.
DB00656
The risk or severity of adverse effects can be increased when Butalbital is combined with Trazodone.
DB00715
The risk or severity of adverse effects can be increased when Butalbital is combined with Paroxetine.
DB01104
The risk or severity of adverse effects can be increased when Butalbital is combined with Sertraline.
DB01105
The risk or severity of adverse effects can be increased when Butalbital is combined with Sibutramine.
DB01149
The risk or severity of adverse effects can be increased when Butalbital is combined with Nefazodone.
DB01175
The risk or severity of adverse effects can be increased when Butalbital is combined with Escitalopram.
DB04832
The risk or severity of adverse effects can be increased when Butalbital is combined with Zimelidine.
DB04884
The risk or severity of adverse effects can be increased when Butalbital is combined with Dapoxetine.
DB06700
The risk or severity of adverse effects can be increased when Butalbital is combined with Desvenlafaxine.
DB06731
The risk or severity of adverse effects can be increased when Butalbital is combined with Seproxetine.
DB08953
The risk or severity of adverse effects can be increased when Butalbital is combined with Indalpine.
DB12693
The risk or severity of adverse effects can be increased when Butalbital is combined with Ritanserin.
DB13233
The risk or severity of adverse effects can be increased when Butalbital is combined with Alaproclate.
DB00704
The risk or severity of adverse effects can be increased when Butalbital is combined with Naltrexone.
DB01459
The risk or severity of adverse effects can be increased when Butalbital is combined with Bezitramide.
DB00295
The risk or severity of adverse effects can be increased when Butalbital is combined with Morphine.
DB00327
The risk or severity of adverse effects can be increased when Butalbital is combined with Hydromorphone.
DB00497
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxycodone.
DB00611
The risk or severity of adverse effects can be increased when Butalbital is combined with Butorphanol.
DB00647
The risk or severity of adverse effects can be increased when Butalbital is combined with Dextropropoxyphene.
DB00652
The risk or severity of adverse effects can be increased when Butalbital is combined with Pentazocine.
DB00708
The risk or severity of adverse effects can be increased when Butalbital is combined with Sufentanil.
DB00844
The risk or severity of adverse effects can be increased when Butalbital is combined with Nalbuphine.
DB00854
The risk or severity of adverse effects can be increased when Butalbital is combined with Levorphanol.
DB00899
The risk or severity of adverse effects can be increased when Butalbital is combined with Remifentanil.
DB01081
The risk or severity of adverse effects can be increased when Butalbital is combined with Diphenoxylate.
DB01192
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxymorphone.
DB01209
The risk or severity of adverse effects can be increased when Butalbital is combined with Dezocine.
DB01433
The risk or severity of adverse effects can be increased when Butalbital is combined with Methadyl acetate.
DB01450
The risk or severity of adverse effects can be increased when Butalbital is combined with Dihydroetorphine.
DB01452
The risk or severity of adverse effects can be increased when Butalbital is combined with Diamorphine.
DB01466
The risk or severity of adverse effects can be increased when Butalbital is combined with Ethylmorphine.
DB01497
The risk or severity of adverse effects can be increased when Butalbital is combined with Etorphine.
DB01529
The risk or severity of adverse effects can be increased when Butalbital is combined with Dextromoramide.
DB01531
The risk or severity of adverse effects can be increased when Butalbital is combined with Desomorphine.
DB01535
The risk or severity of adverse effects can be increased when Butalbital is combined with Carfentanil.
DB01551
The risk or severity of adverse effects can be increased when Butalbital is combined with Dihydrocodeine.
DB01555
The risk or severity of adverse effects can be increased when Butalbital is combined with Alphacetylmethadol.
DB01565
The risk or severity of adverse effects can be increased when Butalbital is combined with Dihydromorphine.
DB06738
The risk or severity of adverse effects can be increased when Butalbital is combined with Ketobemidone.
DB08861
The risk or severity of adverse effects can be increased when Butalbital is combined with DPDPE.
DB09174
The risk or severity of adverse effects can be increased when Butalbital is combined with Lofentanil.
DB11130
The risk or severity of adverse effects can be increased when Butalbital is combined with Opium.
DB11609
The risk or severity of adverse effects can be increased when Butalbital is combined with Normethadone.
DB12492
The risk or severity of adverse effects can be increased when Butalbital is combined with Piritramide.
DB13160
The risk or severity of adverse effects can be increased when Butalbital is combined with Alphaprodine.
DB13454
The risk or severity of adverse effects can be increased when Butalbital is combined with Nicomorphine.
DB13478
The risk or severity of adverse effects can be increased when Butalbital is combined with Meptazinol.
DB13605
The risk or severity of adverse effects can be increased when Butalbital is combined with Phenoperidine.
DB13606
The risk or severity of adverse effects can be increased when Butalbital is combined with Phenazocine.
DB13787
The risk or severity of adverse effects can be increased when Butalbital is combined with Tilidine.
DB15360
The risk or severity of adverse effects can be increased when Butalbital is combined with Carfentanil, C-11.
DB00802
The risk or severity of adverse effects can be increased when Butalbital is combined with Alfentanil.
DB00813
The risk or severity of adverse effects can be increased when Butalbital is combined with Fentanyl.
DB01227
The risk or severity of adverse effects can be increased when Butalbital is combined with Levacetylmethadol.
DB15465
The risk or severity of adverse effects can be increased when Butalbital is combined with Benzhydrocodone.
DB00809
The risk or severity of adverse effects can be increased when Butalbital is combined with Tropicamide.
DB00915
The risk or severity of adverse effects can be increased when Butalbital is combined with Amantadine.
DB00979
The risk or severity of adverse effects can be increased when Butalbital is combined with Cyclopentolate.
DB01090
The risk or severity of adverse effects can be increased when Butalbital is combined with Pentolinium.
DB01116
The risk or severity of adverse effects can be increased when Butalbital is combined with Trimethaphan.
DB01161
The risk or severity of adverse effects can be increased when Butalbital is combined with Chloroprocaine.
DB01288
The risk or severity of adverse effects can be increased when Butalbital is combined with Fenoterol.
DB01496
The risk or severity of adverse effects can be increased when Butalbital is combined with Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione.
DB11181
The risk or severity of adverse effects can be increased when Butalbital is combined with Homatropine.
DB00091
The metabolism of Cyclosporine can be increased when combined with Butalbital.
DB00232
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Methyclothiazide.
DB00310
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Chlorthalidone.
DB00436
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Bendroflumethiazide.
DB00524
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Metolazone.
DB00562
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Benzthiazide.
DB00774
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Hydroflumethiazide.
DB00808
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Indapamide.
DB00880
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Chlorothiazide.
DB00999
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Hydrochlorothiazide.
DB01021
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Trichlormethiazide.
DB01324
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Polythiazide.
DB01325
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Quinethazone.
DB13532
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Cyclopenthiazide.
DB13989
The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Epitizide.
DB00344
The metabolism of Protriptyline can be increased when combined with Butalbital.
DB00543
The metabolism of Amoxapine can be increased when combined with Butalbital.
DB01151
The metabolism of Desipramine can be increased when combined with Butalbital.
DB04836
The metabolism of Amineptine can be increased when combined with Butalbital.
DB08996
The metabolism of Dimetacrine can be increased when combined with Butalbital.
DB09016
The metabolism of Butriptyline can be increased when combined with Butalbital.
DB09167
The metabolism of Dosulepin can be increased when combined with Butalbital.
DB09307
The metabolism of Oxaprotiline can be increased when combined with Butalbital.
DB12930
The metabolism of Opipramol can be increased when combined with Butalbital.
DB13114
The metabolism of Amitriptylinoxide can be increased when combined with Butalbital.
DB13225
The metabolism of Dibenzepin can be increased when combined with Butalbital.
DB13246
The metabolism of Quinupramine can be increased when combined with Butalbital.
DB13384
The metabolism of Melitracen can be increased when combined with Butalbital.
DB13411
The metabolism of Lofepramine can be increased when combined with Butalbital.
DB13496
The metabolism of Iprindole can be increased when combined with Butalbital.
DB13782
The metabolism of Imipramine oxide can be increased when combined with Butalbital.
DB00266
The metabolism of Dicoumarol can be increased when combined with Butalbital.
DB00498
The metabolism of Phenindione can be increased when combined with Butalbital.
DB04665
The metabolism of Coumarin can be increased when combined with Butalbital.
DB13451
The metabolism of Tioclomarol can be increased when combined with Butalbital.
DB08794
The metabolism of Ethyl biscoumacetate can be increased when combined with Butalbital.
DB13347
The metabolism of Diphenadione can be increased when combined with Butalbital.
DB03410
The metabolism of 4-hydroxycoumarin can be increased when combined with Butalbital.
DB13136
The metabolism of Fluindione can be increased when combined with Butalbital.
DB13275
The metabolism of Clorindione can be increased when combined with Butalbital.
DB00250
The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Butalbital.
DB00530
The serum concentration of Erlotinib can be decreased when it is combined with Butalbital.
DB00082
The therapeutic efficacy of Butalbital can be decreased when used in combination with Pegvisomant.
DB00382
The therapeutic efficacy of Butalbital can be decreased when used in combination with Tacrine.
DB00515
The therapeutic efficacy of Butalbital can be decreased when used in combination with Cisplatin.
DB00527
The therapeutic efficacy of Butalbital can be decreased when used in combination with Cinchocaine.
DB00545
The therapeutic efficacy of Butalbital can be decreased when used in combination with Pyridostigmine.
DB00585
The therapeutic efficacy of Butalbital can be decreased when used in combination with Nizatidine.
DB00674
The therapeutic efficacy of Butalbital can be decreased when used in combination with Galantamine.
DB00677
The therapeutic efficacy of Butalbital can be decreased when used in combination with Isoflurophate.
DB00711
The therapeutic efficacy of Butalbital can be decreased when used in combination with Diethylcarbamazine.
DB00871
The therapeutic efficacy of Butalbital can be decreased when used in combination with Terbutaline.
DB00888
The therapeutic efficacy of Butalbital can be decreased when used in combination with Mechlorethamine.
DB00944
The therapeutic efficacy of Butalbital can be decreased when used in combination with Demecarium.
DB00981
The therapeutic efficacy of Butalbital can be decreased when used in combination with Physostigmine.
DB00989
The therapeutic efficacy of Butalbital can be decreased when used in combination with Rivastigmine.
DB01010
The therapeutic efficacy of Butalbital can be decreased when used in combination with Edrophonium.
DB01035
The therapeutic efficacy of Butalbital can be decreased when used in combination with Procainamide.
DB01043
The therapeutic efficacy of Butalbital can be decreased when used in combination with Memantine.
DB01122
The therapeutic efficacy of Butalbital can be decreased when used in combination with Ambenonium.
DB01381
The therapeutic efficacy of Butalbital can be decreased when used in combination with Ginkgo biloba.
DB01400
The therapeutic efficacy of Butalbital can be decreased when used in combination with Neostigmine.
DB01408
The therapeutic efficacy of Butalbital can be decreased when used in combination with Bambuterol.
DB02365
The therapeutic efficacy of Butalbital can be decreased when used in combination with 1,10-Phenanthroline.
DB04864
The therapeutic efficacy of Butalbital can be decreased when used in combination with Huperzine A.
DB04892
The therapeutic efficacy of Butalbital can be decreased when used in combination with Phenserine.
DB05386
The therapeutic efficacy of Butalbital can be decreased when used in combination with Regramostim.
DB06692
The therapeutic efficacy of Butalbital can be decreased when used in combination with Aprotinin.
DB06756
The therapeutic efficacy of Butalbital can be decreased when used in combination with Glycine betaine.
DB06774
The therapeutic efficacy of Butalbital can be decreased when used in combination with Capsaicin.
DB11390
The therapeutic efficacy of Butalbital can be decreased when used in combination with Coumaphos.
DB11397
The therapeutic efficacy of Butalbital can be decreased when used in combination with Dichlorvos.
DB11412
The therapeutic efficacy of Butalbital can be decreased when used in combination with Fenthion.
DB11473
The therapeutic efficacy of Butalbital can be decreased when used in combination with Metrifonate.
DB12482
The therapeutic efficacy of Butalbital can be decreased when used in combination with Acotiamide.
DB13058
The therapeutic efficacy of Butalbital can be decreased when used in combination with Methanesulfonyl Fluoride.
DB13495
The therapeutic efficacy of Butalbital can be decreased when used in combination with Paraoxon.
DB13503
The therapeutic efficacy of Butalbital can be decreased when used in combination with Tyrothricin.
DB13668
The therapeutic efficacy of Butalbital can be decreased when used in combination with Ipidacrine.
DB13694
The therapeutic efficacy of Butalbital can be decreased when used in combination with Distigmine.
DB14031
The therapeutic efficacy of Butalbital can be decreased when used in combination with Tretamine.
DB15317
The therapeutic efficacy of Butalbital can be decreased when used in combination with Posiphen.
DB02845
The therapeutic efficacy of Butalbital can be decreased when used in combination with Methylphosphinic Acid.
DB00392
Profenamine may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00483
Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00508
Triflupromazine may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB01337
Pancuronium may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB01338
Pipecuronium may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
DB00209
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Trospium.
DB00219
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00245
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00332
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.
DB00340
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Metixene.
DB00354
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Buclizine.
DB00376
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
DB00383
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.
DB00387
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.
DB00424
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
DB00434
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.
DB00462
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine bromide.
DB00505
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.
DB00517
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Anisotropine methylbromide.
DB00572
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Atropine.
DB00670
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.
DB00725
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.
DB00767
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Benzquinamide.
DB00777
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.
DB00782
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
DB00804
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
DB00810
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Biperiden.
DB00934
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.
DB00940
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Methantheline.
DB00942
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Cycrimine.
DB00986
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
DB01148
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
DB01231
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Diphenidol.
DB01625
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.
DB04843
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.
DB06153
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.
DB06787
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.
DB08801
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.
DB08897
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Aclidinium.
DB08997
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.
DB09076
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Umeclidinium.
DB09300
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.
DB11235
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.
DB11315
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.
DB11855
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.
DB12086
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Oxitropium.
DB12526
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Batefenterol.
DB12554
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.
DB13252
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.
DB13254
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Prifinium.
DB13351
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.
DB13369
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Benzilone.
DB13380
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Difemerine.
DB13413
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Phenglutarimide.
DB13448
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Mazaticol.
DB13468
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Etybenzatropine.
DB13507
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Poldine.
DB13542
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Bevonium.
DB13581
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Rociverine.
DB13619
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.
DB13636
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Etanautine.
DB13666
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Tiemonium iodide.
DB13678
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.
DB13695
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Penthienate.
DB13720
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.
DB13738
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Camylofin.
DB13759
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Fenpiverinium.
DB13769
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Emetonium iodide.
DB13844
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.
DB13850
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Timepidium.
DB00280
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.
DB00907
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Cocaine.
DB01036
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
DB01062
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
DB01224
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
DB01409
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Tiotropium.
DB01591
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
DB06702
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
DB09262
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Imidafenacin.
DB12278
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Propiverine.
DB00321
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
DB00458
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Imipramine.
DB01142
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
DB00496
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
DB09007
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.
DB00342
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.
DB00363
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Clozapine.
DB00178
Ramipril may increase the hypotensive activities of Butalbital.
DB00477
Chlorpromazine may increase the hypotensive activities of Butalbital.
DB00790
Perindopril may increase the hypotensive activities of Butalbital.
DB00041
Butalbital may increase the hypotensive activities of Aldesleukin.
DB00086
Butalbital may increase the hypotensive activities of Streptokinase.
DB00177
Butalbital may increase the hypotensive activities of Valsartan.
DB00206
Butalbital may increase the hypotensive activities of Reserpine.
DB00214
Butalbital may increase the hypotensive activities of Torasemide.
DB00275
Butalbital may increase the hypotensive activities of Olmesartan.
DB00296
Butalbital may increase the hypotensive activities of Ropivacaine.
DB00297
Butalbital may increase the hypotensive activities of Bupivacaine.
DB00350
Butalbital may increase the hypotensive activities of Minoxidil.
DB00384
Butalbital may increase the hypotensive activities of Triamterene.
DB00421
Butalbital may increase the hypotensive activities of Spironolactone.
DB00457
Butalbital may increase the hypotensive activities of Prazosin.
DB00492
Butalbital may increase the hypotensive activities of Fosinopril.
DB00519
Butalbital may increase the hypotensive activities of Trandolapril.
DB00542
Butalbital may increase the hypotensive activities of Benazepril.
DB00584
Butalbital may increase the hypotensive activities of Enalapril.
DB00590
Butalbital may increase the hypotensive activities of Doxazosin.
DB00594
Butalbital may increase the hypotensive activities of Amiloride.
DB00631
Butalbital may increase the hypotensive activities of Clofarabine.
DB00657
Butalbital may increase the hypotensive activities of Mecamylamine.
DB00678
Butalbital may increase the hypotensive activities of Losartan.
DB00681
Butalbital may increase the hypotensive activities of Amphotericin B.
DB00691
Butalbital may increase the hypotensive activities of Moexipril.
DB00692
Butalbital may increase the hypotensive activities of Phentolamine.
DB00695
Butalbital may increase the hypotensive activities of Furosemide.
DB00703
Butalbital may increase the hypotensive activities of Methazolamide.
DB00706
Butalbital may increase the hypotensive activities of Tamsulosin.
DB00714
Butalbital may increase the hypotensive activities of Apomorphine.
DB00722
Butalbital may increase the hypotensive activities of Lisinopril.
DB00742
Butalbital may increase the hypotensive activities of Mannitol.
DB00752
Butalbital may increase the hypotensive activities of Tranylcypromine.
DB00755
Butalbital may increase the hypotensive activities of Tretinoin.
DB00780
Butalbital may increase the hypotensive activities of Phenelzine.
DB00796
Butalbital may increase the hypotensive activities of Candesartan cilexetil.
DB00797
Butalbital may increase the hypotensive activities of Tolazoline.
DB00800
Butalbital may increase the hypotensive activities of Fenoldopam.
DB00876
Butalbital may increase the hypotensive activities of Eprosartan.
DB00881
Butalbital may increase the hypotensive activities of Quinapril.
DB00887
Butalbital may increase the hypotensive activities of Bumetanide.
DB00903
Butalbital may increase the hypotensive activities of Etacrynic acid.
DB00922
Butalbital may increase the hypotensive activities of Levosimendan.
DB00925
Butalbital may increase the hypotensive activities of Phenoxybenzamine.
DB00966
Butalbital may increase the hypotensive activities of Telmisartan.
DB00968
Butalbital may increase the hypotensive activities of Methyldopa.
DB00975
Butalbital may increase the hypotensive activities of Dipyridamole.
DB01002
Butalbital may increase the hypotensive activities of Levobupivacaine.
DB01029
Butalbital may increase the hypotensive activities of Irbesartan.
DB01037
Butalbital may increase the hypotensive activities of Selegiline.
DB01088
Butalbital may increase the hypotensive activities of Iloprost.
DB01113
Butalbital may increase the hypotensive activities of Papaverine.
DB01119
Butalbital may increase the hypotensive activities of Diazoxide.
DB01143
Butalbital may increase the hypotensive activities of Amifostine.
DB01144
Butalbital may increase the hypotensive activities of Diclofenamide.
DB01158
Butalbital may increase the hypotensive activities of Bretylium.
DB01162
Butalbital may increase the hypotensive activities of Terazosin.
DB01169
Butalbital may increase the hypotensive activities of Arsenic trioxide.
DB01197
Butalbital may increase the hypotensive activities of Captopril.
DB01240
Butalbital may increase the hypotensive activities of Epoprostenol.
DB01247
Butalbital may increase the hypotensive activities of Isocarboxazid.
DB01275
Butalbital may increase the hypotensive activities of Hydralazine.
DB01282
Butalbital may increase the hypotensive activities of Carbetocin.
DB01340
Butalbital may increase the hypotensive activities of Cilazapril.
DB01367
Butalbital may increase the hypotensive activities of Rasagiline.
DB04899
Butalbital may increase the hypotensive activities of Nesiritide.
DB06292
Butalbital may increase the hypotensive activities of Dapagliflozin.
DB08822
Butalbital may increase the hypotensive activities of Azilsartan medoxomil.
DB08931
Butalbital may increase the hypotensive activities of Riociguat.
DB08935
Butalbital may increase the hypotensive activities of Obinutuzumab.
DB08941
Butalbital may increase the hypotensive activities of Isoxsuprine.
DB08950
Butalbital may increase the hypotensive activities of Indoramin.
DB09026
Butalbital may increase the hypotensive activities of Aliskiren.
DB09038
Butalbital may increase the hypotensive activities of Empagliflozin.
DB09077
Butalbital may increase the hypotensive activities of Dinutuximab.
DB09112
Butalbital may increase the hypotensive activities of Nitrous acid.
DB09242
Butalbital may increase the hypotensive activities of Moxonidine.
DB09279
Butalbital may increase the hypotensive activities of Fimasartan.
DB09286
Butalbital may increase the hypotensive activities of Pipamperone.
DB09292
Butalbital may increase the hypotensive activities of Sacubitril.
DB09477
Butalbital may increase the hypotensive activities of Enalaprilat.
DB11783
Butalbital may increase the hypotensive activities of Imidapril.
DB01115
Butalbital may increase the hypotensive activities of Nifedipine.
DB00401
Butalbital may increase the hypotensive activities of Nisoldipine.
DB00700
Butalbital may increase the hypotensive activities of Eplerenone.
DB01023
Butalbital may increase the hypotensive activities of Felodipine.
DB00187
The serum concentration of Esmolol can be decreased when it is combined with Butalbital.
DB00195
The serum concentration of Betaxolol can be decreased when it is combined with Butalbital.
DB00264
The serum concentration of Metoprolol can be decreased when it is combined with Butalbital.
DB00335
The serum concentration of Atenolol can be decreased when it is combined with Butalbital.
DB00373
The serum concentration of Timolol can be decreased when it is combined with Butalbital.
DB00489
The serum concentration of Sotalol can be decreased when it is combined with Butalbital.
DB00571
The serum concentration of Propranolol can be decreased when it is combined with Butalbital.
DB00598
The serum concentration of Labetalol can be decreased when it is combined with Butalbital.
DB00612
The serum concentration of Bisoprolol can be decreased when it is combined with Butalbital.
DB00866
The serum concentration of Alprenolol can be decreased when it is combined with Butalbital.
DB00960
The serum concentration of Pindolol can be decreased when it is combined with Butalbital.
DB01136
The serum concentration of Carvedilol can be decreased when it is combined with Butalbital.
DB01182
The serum concentration of Propafenone can be decreased when it is combined with Butalbital.
DB01193
The serum concentration of Acebutolol can be decreased when it is combined with Butalbital.
DB01203
The serum concentration of Nadolol can be decreased when it is combined with Butalbital.
DB01295
The serum concentration of Bevantolol can be decreased when it is combined with Butalbital.
DB01297
The serum concentration of Practolol can be decreased when it is combined with Butalbital.
DB01359
The serum concentration of Penbutolol can be decreased when it is combined with Butalbital.
DB01580
The serum concentration of Oxprenolol can be decreased when it is combined with Butalbital.
DB03322
The serum concentration of Dexpropranolol can be decreased when it is combined with Butalbital.
DB04846
The serum concentration of Celiprolol can be decreased when it is combined with Butalbital.
DB04861
The serum concentration of Nebivolol can be decreased when it is combined with Butalbital.
DB06726
The serum concentration of Bufuralol can be decreased when it is combined with Butalbital.
DB08807
The serum concentration of Bopindolol can be decreased when it is combined with Butalbital.
DB08808
The serum concentration of Bupranolol can be decreased when it is combined with Butalbital.
DB08952
The serum concentration of Indenolol can be decreased when it is combined with Butalbital.
DB09204
The serum concentration of Arotinolol can be decreased when it is combined with Butalbital.
DB09351
The serum concentration of Levobetaxolol can be decreased when it is combined with Butalbital.
DB11770
The serum concentration of Talinolol can be decreased when it is combined with Butalbital.
DB11785
The serum concentration of Anisodamine can be decreased when it is combined with Butalbital.
DB12752
The serum concentration of Bucindolol can be decreased when it is combined with Butalbital.
DB13443
The serum concentration of Esatenolol can be decreased when it is combined with Butalbital.
DB13508
The serum concentration of Cloranolol can be decreased when it is combined with Butalbital.
DB13530
The serum concentration of Mepindolol can be decreased when it is combined with Butalbital.
DB13757
The serum concentration of Epanolol can be decreased when it is combined with Butalbital.
DB13775
The serum concentration of Tertatolol can be decreased when it is combined with Butalbital.
DB12212
The serum concentration of Landiolol can be decreased when it is combined with Butalbital.
DB00270
The metabolism of Isradipine can be increased when combined with Butalbital.
DB00343
The metabolism of Diltiazem can be increased when combined with Butalbital.
DB00393
The metabolism of Nimodipine can be increased when combined with Butalbital.
DB00528
The metabolism of Lercanidipine can be increased when combined with Butalbital.
DB00568
The metabolism of Cinnarizine can be increased when combined with Butalbital.
DB00622
The metabolism of Nicardipine can be increased when combined with Butalbital.
DB00661
The metabolism of Verapamil can be increased when combined with Butalbital.
DB00836
The metabolism of Loperamide can be increased when combined with Butalbital.
DB01054
The metabolism of Nitrendipine can be increased when combined with Butalbital.
DB01244
The metabolism of Bepridil can be increased when combined with Butalbital.
DB01388
The metabolism of Mibefradil can be increased when combined with Butalbital.
DB04743
The metabolism of Nimesulide can be increased when combined with Butalbital.
DB04825
The metabolism of Prenylamine can be increased when combined with Butalbital.
DB04838
The metabolism of Cyclandelate can be increased when combined with Butalbital.
DB04842
The metabolism of Fluspirilene can be increased when combined with Butalbital.
DB04920
The metabolism of Clevidipine can be increased when combined with Butalbital.
DB05885
The metabolism of Seletracetam can be increased when combined with Butalbital.
DB06152
The metabolism of Nylidrin can be increased when combined with Butalbital.
DB06446
The metabolism of Dotarizine can be increased when combined with Butalbital.
DB06694
The metabolism of Xylometazoline can be increased when combined with Butalbital.
DB06712
The metabolism of Nilvadipine can be increased when combined with Butalbital.
DB07615
The metabolism of Tranilast can be increased when combined with Butalbital.
DB08162
The metabolism of Fasudil can be increased when combined with Butalbital.
DB08838
The metabolism of Agmatine can be increased when combined with Butalbital.
DB08980
The metabolism of Fendiline can be increased when combined with Butalbital.
DB09089
The metabolism of Trimebutine can be increased when combined with Butalbital.
DB09090
The metabolism of Pinaverium can be increased when combined with Butalbital.
DB09216
The metabolism of Tolfenamic acid can be increased when combined with Butalbital.
DB09227
The metabolism of Barnidipine can be increased when combined with Butalbital.
DB09229
The metabolism of Aranidipine can be increased when combined with Butalbital.
DB09230
The metabolism of Azelnidipine can be increased when combined with Butalbital.
DB09231
The metabolism of Benidipine can be increased when combined with Butalbital.
DB09232
The metabolism of Cilnidipine can be increased when combined with Butalbital.
DB09234
The metabolism of Darodipine can be increased when combined with Butalbital.
DB09235
The metabolism of Efonidipine can be increased when combined with Butalbital.
DB09236
The metabolism of Lacidipine can be increased when combined with Butalbital.
DB09238
The metabolism of Manidipine can be increased when combined with Butalbital.
DB09239
The metabolism of Niguldipine can be increased when combined with Butalbital.
DB09240
The metabolism of Niludipine can be increased when combined with Butalbital.
DB11960
The metabolism of Carboxyamidotriazole can be increased when combined with Butalbital.
DB12092
The metabolism of Naftopidil can be increased when combined with Butalbital.
DB12923
The metabolism of Gallopamil can be increased when combined with Butalbital.
DB13488
The metabolism of Bencyclane can be increased when combined with Butalbital.
DB13500
The metabolism of Otilonium can be increased when combined with Butalbital.
DB13725
The metabolism of Terodiline can be increased when combined with Butalbital.
DB13766
The metabolism of Lidoflazine can be increased when combined with Butalbital.
DB13835
The metabolism of Caroverine can be increased when combined with Butalbital.
DB13961
The metabolism of Fish oil can be increased when combined with Butalbital.
DB14063
The metabolism of Dexverapamil can be increased when combined with Butalbital.
DB14064
The metabolism of Emopamil can be increased when combined with Butalbital.
DB14065
The metabolism of Lomerizine can be increased when combined with Butalbital.
DB14066
The metabolism of Tetrandrine can be increased when combined with Butalbital.
DB14068
The metabolism of Dexniguldipine can be increased when combined with Butalbital.
DB01074
The metabolism of Perhexiline can be increased when combined with Butalbital.
DB00651
The serum concentration of Dyphylline can be decreased when it is combined with Butalbital.
DB00806
The serum concentration of Pentoxifylline can be decreased when it is combined with Butalbital.
DB01033
The serum concentration of Mercaptopurine can be decreased when it is combined with Butalbital.
DB01303
The serum concentration of Oxtriphylline can be decreased when it is combined with Butalbital.
DB01412
The serum concentration of Theobromine can be decreased when it is combined with Butalbital.
DB01482
The serum concentration of Fenethylline can be decreased when it is combined with Butalbital.
DB01667
The serum concentration of 8-azaguanine can be decreased when it is combined with Butalbital.
DB01978
The serum concentration of 7,9-Dimethylguanine can be decreased when it is combined with Butalbital.
DB02134
The serum concentration of Xanthine can be decreased when it is combined with Butalbital.
DB02245
The serum concentration of 7-Deazaguanine can be decreased when it is combined with Butalbital.
DB02377
The serum concentration of Guanine can be decreased when it is combined with Butalbital.
DB02489
The serum concentration of 9-Methylguanine can be decreased when it is combined with Butalbital.
DB02568
The serum concentration of Peldesine can be decreased when it is combined with Butalbital.
DB04076
The serum concentration of Hypoxanthine can be decreased when it is combined with Butalbital.
DB04356
The serum concentration of 9-Deazaguanine can be decreased when it is combined with Butalbital.
DB06479
The serum concentration of Propentofylline can be decreased when it is combined with Butalbital.
DB06575
The serum concentration of Valomaciclovir can be decreased when it is combined with Butalbital.
DB07954
The serum concentration of 3-isobutyl-1-methyl-7H-xanthine can be decreased when it is combined with Butalbital.
DB08844
The serum concentration of Uric acid can be decreased when it is combined with Butalbital.
DB09273
The serum concentration of Doxofylline can be decreased when it is combined with Butalbital.
DB11919
The serum concentration of 6-O-benzylguanine can be decreased when it is combined with Butalbital.
DB12406
The serum concentration of Lisofylline can be decreased when it is combined with Butalbital.
DB12531
The serum concentration of Lobucavir can be decreased when it is combined with Butalbital.
DB12926
The serum concentration of Cafedrine can be decreased when it is combined with Butalbital.
DB12927
The serum concentration of Theodrenaline can be decreased when it is combined with Butalbital.
DB13203
The serum concentration of Bamifylline can be decreased when it is combined with Butalbital.
DB13449
The serum concentration of Proxyphylline can be decreased when it is combined with Butalbital.
DB13573
The serum concentration of Acefylline can be decreased when it is combined with Butalbital.
DB13592
The serum concentration of Etamiphylline can be decreased when it is combined with Butalbital.
DB13634
The serum concentration of Pentifylline can be decreased when it is combined with Butalbital.
DB13812
The serum concentration of Bufylline can be decreased when it is combined with Butalbital.
DB14018
The serum concentration of Bromotheophylline can be decreased when it is combined with Butalbital.
DB14029
The serum concentration of Furafylline can be decreased when it is combined with Butalbital.
DB14132
The serum concentration of 8-chlorotheophylline can be decreased when it is combined with Butalbital.
DB15122
The serum concentration of PCS-499 can be decreased when it is combined with Butalbital.
DB00313
The serum concentration of Butalbital can be increased when it is combined with Valproic acid.
DB00391
The risk or severity of adverse effects can be increased when Sulpiride is combined with Butalbital.
DB00721
The risk or severity of adverse effects can be increased when Procaine is combined with Butalbital.
DB00805
The risk or severity of adverse effects can be increased when Minaprine is combined with Butalbital.
DB00941
The risk or severity of adverse effects can be increased when Hexafluronium is combined with Butalbital.
DB01199
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Butalbital.
DB01221
The risk or severity of adverse effects can be increased when Ketamine is combined with Butalbital.
DB01245
The risk or severity of adverse effects can be increased when Decamethonium is combined with Butalbital.
DB00150
The risk or severity of adverse effects can be increased when Tryptophan is combined with Butalbital.
DB00181
The risk or severity of adverse effects can be increased when Baclofen is combined with Butalbital.
DB00182
The risk or severity of adverse effects can be increased when Amphetamine is combined with Butalbital.
DB00186
The risk or severity of adverse effects can be increased when Lorazepam is combined with Butalbital.
DB00189
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Butalbital.
DB00202
The risk or severity of adverse effects can be increased when Succinylcholine is combined with Butalbital.
DB00228
The risk or severity of adverse effects can be increased when Enflurane is combined with Butalbital.
DB00231
The risk or severity of adverse effects can be increased when Temazepam is combined with Butalbital.
DB00234
The risk or severity of adverse effects can be increased when Reboxetine is combined with Butalbital.
DB00237
The risk or severity of adverse effects can be increased when Butabarbital is combined with Butalbital.
DB00273
The risk or severity of adverse effects can be increased when Butalbital is combined with Topiramate.
DB00283
The risk or severity of adverse effects can be increased when Butalbital is combined with Clemastine.
DB00285
The risk or severity of adverse effects can be increased when Butalbital is combined with Venlafaxine.
DB00289
The risk or severity of adverse effects can be increased when Butalbital is combined with Atomoxetine.
DB00292
The risk or severity of adverse effects can be increased when Butalbital is combined with Etomidate.
DB00306
The risk or severity of adverse effects can be increased when Butalbital is combined with Talbutal.
DB00312
The risk or severity of adverse effects can be increased when Butalbital is combined with Pentobarbital.
DB00315
The risk or severity of adverse effects can be increased when Butalbital is combined with Zolmitriptan.
DB00323
The risk or severity of adverse effects can be increased when Butalbital is combined with Tolcapone.
DB00334
The risk or severity of adverse effects can be increased when Butalbital is combined with Olanzapine.
DB00341
The risk or severity of adverse effects can be increased when Butalbital is combined with Cetirizine.
DB00347
The risk or severity of adverse effects can be increased when Butalbital is combined with Trimethadione.
DB00349
The risk or severity of adverse effects can be increased when Butalbital is combined with Clobazam.
DB00356
The risk or severity of adverse effects can be increased when Butalbital is combined with Chlorzoxazone.
DB00371
The risk or severity of adverse effects can be increased when Butalbital is combined with Meprobamate.
DB00372
The risk or severity of adverse effects can be increased when Butalbital is combined with Thiethylperazine.
DB00377
The risk or severity of adverse effects can be increased when Butalbital is combined with Palonosetron.
DB00405
The risk or severity of adverse effects can be increased when Butalbital is combined with Dexbrompheniramine.
DB00408
The risk or severity of adverse effects can be increased when Butalbital is combined with Loxapine.
DB00409
The risk or severity of adverse effects can be increased when Butalbital is combined with Remoxipride.
DB00416
The risk or severity of adverse effects can be increased when Butalbital is combined with Metocurine iodide.
DB00418
The risk or severity of adverse effects can be increased when Butalbital is combined with Secobarbital.
DB00420
The risk or severity of adverse effects can be increased when Butalbital is combined with Promazine.
DB00423
The risk or severity of adverse effects can be increased when Butalbital is combined with Methocarbamol.
DB00427
The risk or severity of adverse effects can be increased when Butalbital is combined with Triprolidine.
DB00433
The risk or severity of adverse effects can be increased when Butalbital is combined with Prochlorperazine.
DB00463
The risk or severity of adverse effects can be increased when Butalbital is combined with Metharbital.
DB00474
The risk or severity of adverse effects can be increased when Butalbital is combined with Methohexital.
DB00475
The risk or severity of adverse effects can be increased when Butalbital is combined with Chlordiazepoxide.
DB00494
The risk or severity of adverse effects can be increased when Butalbital is combined with Entacapone.
DB00514
The risk or severity of adverse effects can be increased when Butalbital is combined with Dextromethorphan.
DB00532
The risk or severity of adverse effects can be increased when Butalbital is combined with Mephenytoin.
DB00546
The risk or severity of adverse effects can be increased when Butalbital is combined with Adinazolam.
DB00565
The risk or severity of adverse effects can be increased when Butalbital is combined with Cisatracurium.
DB00574
The risk or severity of adverse effects can be increased when Butalbital is combined with Fenfluramine.
DB00579
The risk or severity of adverse effects can be increased when Butalbital is combined with Mazindol.
DB00588
The risk or severity of adverse effects can be increased when Butalbital is combined with Fluticasone propionate.
DB00589
The risk or severity of adverse effects can be increased when Butalbital is combined with Lisuride.
DB00599
The risk or severity of adverse effects can be increased when Butalbital is combined with Thiopental.
DB00601
The risk or severity of adverse effects can be increased when Butalbital is combined with Linezolid.
DB00614
The risk or severity of adverse effects can be increased when Butalbital is combined with Furazolidone.
DB00617
The risk or severity of adverse effects can be increased when Butalbital is combined with Paramethadione.
DB00623
The risk or severity of adverse effects can be increased when Butalbital is combined with Fluphenazine.
DB00625
The risk or severity of adverse effects can be increased when Butalbital is combined with Efavirenz.
DB00628
The risk or severity of adverse effects can be increased when Butalbital is combined with Clorazepic acid.
DB00633
The risk or severity of adverse effects can be increased when Butalbital is combined with Dexmedetomidine.
DB00645
The risk or severity of adverse effects can be increased when Butalbital is combined with Dyclonine.
DB00660
The risk or severity of adverse effects can be increased when Butalbital is combined with Metaxalone.
DB00662
The risk or severity of adverse effects can be increased when Butalbital is combined with Trimethobenzamide.
DB00669
The risk or severity of adverse effects can be increased when Butalbital is combined with Sumatriptan.
DB00679
The risk or severity of adverse effects can be increased when Butalbital is combined with Thioridazine.
DB00680
The risk or severity of adverse effects can be increased when Butalbital is combined with Moricizine.
DB00690
The risk or severity of adverse effects can be increased when Butalbital is combined with Flurazepam.
DB00697
The risk or severity of adverse effects can be increased when Butalbital is combined with Tizanidine.
DB00728
The risk or severity of adverse effects can be increased when Butalbital is combined with Rocuronium.
DB00732
The risk or severity of adverse effects can be increased when Butalbital is combined with Atracurium besylate.
DB00734
The risk or severity of adverse effects can be increased when Butalbital is combined with Risperidone.
DB00737
The risk or severity of adverse effects can be increased when Butalbital is combined with Meclizine.
DB00740
The risk or severity of adverse effects can be increased when Butalbital is combined with Riluzole.
DB00747
The risk or severity of adverse effects can be increased when Butalbital is combined with Scopolamine.
DB00748
The risk or severity of adverse effects can be increased when Butalbital is combined with Carbinoxamine.
DB00753
The risk or severity of adverse effects can be increased when Butalbital is combined with Isoflurane.
DB00754
The risk or severity of adverse effects can be increased when Butalbital is combined with Ethotoin.
DB00757
The risk or severity of adverse effects can be increased when Butalbital is combined with Dolasetron.
DB00771
The risk or severity of adverse effects can be increased when Butalbital is combined with Clidinium.
DB00776
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxcarbazepine.
DB00801
The risk or severity of adverse effects can be increased when Butalbital is combined with Halazepam.
DB00818
The risk or severity of adverse effects can be increased when Butalbital is combined with Propofol.
DB00819
The risk or severity of adverse effects can be increased when Butalbital is combined with Acetazolamide.
DB00829
The risk or severity of adverse effects can be increased when Butalbital is combined with Diazepam.
DB00831
The risk or severity of adverse effects can be increased when Butalbital is combined with Trifluoperazine.
DB00832
The risk or severity of adverse effects can be increased when Butalbital is combined with Phensuximide.
DB00835
The risk or severity of adverse effects can be increased when Butalbital is combined with Brompheniramine.
DB00837
The risk or severity of adverse effects can be increased when Butalbital is combined with Progabide.
DB00842
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxazepam.
DB00850
The risk or severity of adverse effects can be increased when Butalbital is combined with Perphenazine.
DB00865
The risk or severity of adverse effects can be increased when Butalbital is combined with Benzphetamine.
DB00875
The risk or severity of adverse effects can be increased when Butalbital is combined with Flupentixol.
DB00889
The risk or severity of adverse effects can be increased when Butalbital is combined with Granisetron.
DB00904
The risk or severity of adverse effects can be increased when Butalbital is combined with Ondansetron.
DB00906
The risk or severity of adverse effects can be increased when Butalbital is combined with Tiagabine.
DB00909
The risk or severity of adverse effects can be increased when Butalbital is combined with Zonisamide.
DB00918
The risk or severity of adverse effects can be increased when Butalbital is combined with Almotriptan.
DB00933
The risk or severity of adverse effects can be increased when Butalbital is combined with Mesoridazine.
DB00937
The risk or severity of adverse effects can be increased when Butalbital is combined with Diethylpropion.
DB00952
The risk or severity of adverse effects can be increased when Butalbital is combined with Naratriptan.
DB00953
The risk or severity of adverse effects can be increased when Butalbital is combined with Rizatriptan.
DB00962
The risk or severity of adverse effects can be increased when Butalbital is combined with Zaleplon.
DB00969
The risk or severity of adverse effects can be increased when Butalbital is combined with Alosetron.
DB00980
The risk or severity of adverse effects can be increased when Butalbital is combined with Ramelteon.
DB00985
The risk or severity of adverse effects can be increased when Butalbital is combined with Dimenhydrinate.
DB00996
The risk or severity of adverse effects can be increased when Butalbital is combined with Gabapentin.
DB00998
The risk or severity of adverse effects can be increased when Butalbital is combined with Frovatriptan.
DB01018
The risk or severity of adverse effects can be increased when Butalbital is combined with Guanfacine.
DB01028
The risk or severity of adverse effects can be increased when Butalbital is combined with Methoxyflurane.
DB01049
The risk or severity of adverse effects can be increased when Butalbital is combined with Ergoloid mesylate.
DB01063
The risk or severity of adverse effects can be increased when Butalbital is combined with Acetophenazine.
DB01065
The risk or severity of adverse effects can be increased when Butalbital is combined with Melatonin.
DB01069
The risk or severity of adverse effects can be increased when Butalbital is combined with Promethazine.
DB01075
The risk or severity of adverse effects can be increased when Butalbital is combined with Diphenhydramine.
DB01080
The risk or severity of adverse effects can be increased when Butalbital is combined with Vigabatrin.
DB01107
The risk or severity of adverse effects can be increased when Butalbital is combined with Methyprylon.
DB01114
The risk or severity of adverse effects can be increased when Butalbital is combined with Chlorpheniramine.
DB01121
The risk or severity of adverse effects can be increased when Butalbital is combined with Phenacemide.
DB01135
The risk or severity of adverse effects can be increased when Butalbital is combined with Doxacurium.
DB01154
The risk or severity of adverse effects can be increased when Butalbital is combined with Thiamylal.
DB01156
The risk or severity of adverse effects can be increased when Butalbital is combined with Bupropion.
DB01159
The risk or severity of adverse effects can be increased when Butalbital is combined with Halothane.
DB01168
The risk or severity of adverse effects can be increased when Butalbital is combined with Procarbazine.
DB01171
The risk or severity of adverse effects can be increased when Butalbital is combined with Moclobemide.
DB01176
The risk or severity of adverse effects can be increased when Butalbital is combined with Cyclizine.
DB01178
The risk or severity of adverse effects can be increased when Butalbital is combined with Chlormezanone.
DB01186
The risk or severity of adverse effects can be increased when Butalbital is combined with Pergolide.
DB01189
The risk or severity of adverse effects can be increased when Butalbital is combined with Desflurane.
DB01202
The risk or severity of adverse effects can be increased when Butalbital is combined with Levetiracetam.
DB01215
The risk or severity of adverse effects can be increased when Butalbital is combined with Estazolam.
DB01219
The risk or severity of adverse effects can be increased when Butalbital is combined with Dantrolene.
DB01226
The risk or severity of adverse effects can be increased when Butalbital is combined with Mivacurium.
DB01235
The risk or severity of adverse effects can be increased when Butalbital is combined with Levodopa.
DB01236
The risk or severity of adverse effects can be increased when Butalbital is combined with Sevoflurane.
DB01239
The risk or severity of adverse effects can be increased when Butalbital is combined with Chlorprothixene.
DB01246
The risk or severity of adverse effects can be increased when Butalbital is combined with Alimemazine.
DB01253
The risk or severity of adverse effects can be increased when Butalbital is combined with Ergometrine.
DB01267
The risk or severity of adverse effects can be increased when Butalbital is combined with Paliperidone.
DB01323
The risk or severity of adverse effects can be increased when Butalbital is combined with St. John's Wort.
DB01336
The risk or severity of adverse effects can be increased when Butalbital is combined with Metocurine.
DB01339
The risk or severity of adverse effects can be increased when Butalbital is combined with Vecuronium.
DB01351
The risk or severity of adverse effects can be increased when Butalbital is combined with Amobarbital.
DB01352
The risk or severity of adverse effects can be increased when Butalbital is combined with Aprobarbital.
DB01353
The risk or severity of adverse effects can be increased when Butalbital is combined with Butobarbital.
DB01354
The risk or severity of adverse effects can be increased when Butalbital is combined with Heptabarbital.
DB01355
The risk or severity of adverse effects can be increased when Butalbital is combined with Hexobarbital.
DB01392
The risk or severity of adverse effects can be increased when Butalbital is combined with Yohimbine.
DB01437
The risk or severity of adverse effects can be increased when Butalbital is combined with Glutethimide.
DB01440
The risk or severity of adverse effects can be increased when Butalbital is combined with gamma-Hydroxybutyric acid.
DB01442
The risk or severity of adverse effects can be increased when Butalbital is combined with MMDA.
DB01445
The risk or severity of adverse effects can be increased when Butalbital is combined with Bufotenine.
DB01454
The risk or severity of adverse effects can be increased when Butalbital is combined with Midomafetamine.
DB01463
The risk or severity of adverse effects can be increased when Butalbital is combined with Fencamfamin.
DB01472
The risk or severity of adverse effects can be increased when Butalbital is combined with 4-Methoxyamphetamine.
DB01483
The risk or severity of adverse effects can be increased when Butalbital is combined with Barbital.
DB01484
The risk or severity of adverse effects can be increased when Butalbital is combined with 4-Bromo-2,5-dimethoxyamphetamine.
DB01488
The risk or severity of adverse effects can be increased when Butalbital is combined with Dimethyltryptamine.
DB01489
The risk or severity of adverse effects can be increased when Butalbital is combined with Camazepam.
DB01495
The risk or severity of adverse effects can be increased when Butalbital is combined with Dichloralphenazone.
DB01501
The risk or severity of adverse effects can be increased when Butalbital is combined with Difenoxin.
DB01509
The risk or severity of adverse effects can be increased when Butalbital is combined with Tenamfetamine.
DB01511
The risk or severity of adverse effects can be increased when Butalbital is combined with Delorazepam.
DB01534
The risk or severity of adverse effects can be increased when Butalbital is combined with Chlorhexadol.
DB01544
The risk or severity of adverse effects can be increased when Butalbital is combined with Flunitrazepam.
DB01545
The risk or severity of adverse effects can be increased when Butalbital is combined with Ethyl loflazepate.
DB01547
The risk or severity of adverse effects can be increased when Butalbital is combined with Drotebanol.
DB01553
The risk or severity of adverse effects can be increased when Butalbital is combined with Cloxazolam.
DB01558
The risk or severity of adverse effects can be increased when Butalbital is combined with Bromazepam.
DB01559
The risk or severity of adverse effects can be increased when Butalbital is combined with Clotiazepam.
DB01560
The risk or severity of adverse effects can be increased when Butalbital is combined with Cathinone.
DB01563
The risk or severity of adverse effects can be increased when Butalbital is combined with Chloral hydrate.
DB01567
The risk or severity of adverse effects can be increased when Butalbital is combined with Fludiazepam.
DB01577
The risk or severity of adverse effects can be increased when Butalbital is combined with Metamfetamine.
DB01587
The risk or severity of adverse effects can be increased when Butalbital is combined with Ketazolam.
DB01588
The risk or severity of adverse effects can be increased when Butalbital is combined with Prazepam.
DB01589
The risk or severity of adverse effects can be increased when Butalbital is combined with Quazepam.
DB01594
The risk or severity of adverse effects can be increased when Butalbital is combined with Cinolazepam.
DB01595
The risk or severity of adverse effects can be increased when Butalbital is combined with Nitrazepam.
DB01608
The risk or severity of adverse effects can be increased when Butalbital is combined with Periciazine.
DB01614
The risk or severity of adverse effects can be increased when Butalbital is combined with Acepromazine.
DB01615
The risk or severity of adverse effects can be increased when Butalbital is combined with Aceprometazine.
DB01616
The risk or severity of adverse effects can be increased when Butalbital is combined with Alverine.
DB01618
The risk or severity of adverse effects can be increased when Butalbital is combined with Molindone.
DB01621
The risk or severity of adverse effects can be increased when Butalbital is combined with Pipotiazine.
DB01622
The risk or severity of adverse effects can be increased when Butalbital is combined with Thioproperazine.
DB01623
The risk or severity of adverse effects can be increased when Butalbital is combined with Thiothixene.
DB01624
The risk or severity of adverse effects can be increased when Butalbital is combined with Zuclopenthixol.
DB01626
The risk or severity of adverse effects can be increased when Butalbital is combined with Pargyline.
DB01954
The risk or severity of adverse effects can be increased when Butalbital is combined with Rolipram.
DB02207
The risk or severity of adverse effects can be increased when Butalbital is combined with 7-Nitroindazole.
DB02234
The risk or severity of adverse effects can be increased when Butalbital is combined with S-Ethylisothiourea.
DB02852
The risk or severity of adverse effects can be increased when Butalbital is combined with Domoic Acid.
DB02959
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxitriptan.
DB03575
The risk or severity of adverse effects can be increased when Butalbital is combined with Phencyclidine.
DB04017
The risk or severity of adverse effects can be increased when Butalbital is combined with Clorgiline.
DB04165
The risk or severity of adverse effects can be increased when Butalbital is combined with Valpromide.
DB04325
The risk or severity of adverse effects can be increased when Butalbital is combined with Phenethylamine.
DB04599
The risk or severity of adverse effects can be increased when Butalbital is combined with Aniracetam.
DB04818
The risk or severity of adverse effects can be increased when Butalbital is combined with Iproniazid.
DB04819
The risk or severity of adverse effects can be increased when Butalbital is combined with Methapyrilene.
DB04820
The risk or severity of adverse effects can be increased when Butalbital is combined with Nialamide.
DB04821
The risk or severity of adverse effects can be increased when Butalbital is combined with Nomifensine.
DB04827
The risk or severity of adverse effects can be increased when Butalbital is combined with Urethane.
DB04829
The risk or severity of adverse effects can be increased when Butalbital is combined with Lysergic acid diethylamide.
DB04833
The risk or severity of adverse effects can be increased when Butalbital is combined with Methaqualone.
DB04834
The risk or severity of adverse effects can be increased when Butalbital is combined with Rapacuronium.
DB04841
The risk or severity of adverse effects can be increased when Butalbital is combined with Flunarizine.
DB04871
The risk or severity of adverse effects can be increased when Butalbital is combined with Lorcaserin.
DB04872
The risk or severity of adverse effects can be increased when Butalbital is combined with Osanetant.
DB04885
The risk or severity of adverse effects can be increased when Butalbital is combined with Cilansetron.
DB04888
The risk or severity of adverse effects can be increased when Butalbital is combined with Bifeprunox.
DB04903
The risk or severity of adverse effects can be increased when Butalbital is combined with Pagoclone.
DB04908
The risk or severity of adverse effects can be increased when Butalbital is combined with Flibanserin.
DB04917
The risk or severity of adverse effects can be increased when Butalbital is combined with Renzapride.
DB04946
The risk or severity of adverse effects can be increased when Butalbital is combined with Iloperidone.
DB04953
The risk or severity of adverse effects can be increased when Butalbital is combined with Ezogabine.
DB05227
The risk or severity of adverse effects can be increased when Butalbital is combined with APD791.
DB05232
The risk or severity of adverse effects can be increased when Butalbital is combined with Tetrodotoxin.
DB05246
The risk or severity of adverse effects can be increased when Butalbital is combined with Methsuximide.
DB05316
The risk or severity of adverse effects can be increased when Butalbital is combined with Pimavanserin.
DB05541
The risk or severity of adverse effects can be increased when Butalbital is combined with Brivaracetam.
DB05542
The risk or severity of adverse effects can be increased when Butalbital is combined with Naronapride.
DB05562
The risk or severity of adverse effects can be increased when Butalbital is combined with Naluzotan.
DB05607
The risk or severity of adverse effects can be increased when Butalbital is combined with PRX-08066.
DB05687
The risk or severity of adverse effects can be increased when Butalbital is combined with BL-1020.
DB05710
The risk or severity of adverse effects can be increased when Butalbital is combined with Gantacurium.
DB06016
The risk or severity of adverse effects can be increased when Butalbital is combined with Cariprazine.
DB06109
The risk or severity of adverse effects can be increased when Butalbital is combined with YKP-1358.
DB06144
The risk or severity of adverse effects can be increased when Butalbital is combined with Sertindole.
DB06216
The risk or severity of adverse effects can be increased when Butalbital is combined with Asenapine.
DB06218
The risk or severity of adverse effects can be increased when Butalbital is combined with Lacosamide.
DB06264
The risk or severity of adverse effects can be increased when Butalbital is combined with Tolperisone.
DB06282
The risk or severity of adverse effects can be increased when Butalbital is combined with Levocetirizine.
DB06288
The risk or severity of adverse effects can be increased when Butalbital is combined with Amisulpride.
DB06458
The risk or severity of adverse effects can be increased when Butalbital is combined with Remacemide.
DB06470
The risk or severity of adverse effects can be increased when Butalbital is combined with Clomethiazole.
DB06512
The risk or severity of adverse effects can be increased when Butalbital is combined with Deramciclane.
DB06527
The risk or severity of adverse effects can be increased when Butalbital is combined with Tramiprosate.
DB06529
The risk or severity of adverse effects can be increased when Butalbital is combined with Ocinaplon.
DB06554
The risk or severity of adverse effects can be increased when Butalbital is combined with Gaboxadol.
DB06579
The risk or severity of adverse effects can be increased when Butalbital is combined with Adipiplon.
DB06582
The risk or severity of adverse effects can be increased when Butalbital is combined with Dextofisopam.
DB06594
The risk or severity of adverse effects can be increased when Butalbital is combined with Agomelatine.
DB06654
The risk or severity of adverse effects can be increased when Butalbital is combined with Safinamide.
DB06660
The risk or severity of adverse effects can be increased when Butalbital is combined with Saredutant.
DB06678
The risk or severity of adverse effects can be increased when Butalbital is combined with Esmirtazapine.
DB06684
The risk or severity of adverse effects can be increased when Butalbital is combined with Vilazodone.
DB06691
The risk or severity of adverse effects can be increased when Butalbital is combined with Mepyramine.
DB06701
The risk or severity of adverse effects can be increased when Butalbital is combined with Dexmethylphenidate.
DB06716
The risk or severity of adverse effects can be increased when Butalbital is combined with Fospropofol.
DB06753
The risk or severity of adverse effects can be increased when Butalbital is combined with Triclofos.
DB06770
The risk or severity of adverse effects can be increased when Butalbital is combined with Benzyl alcohol.
DB06797
The risk or severity of adverse effects can be increased when Butalbital is combined with Mebutamate.
DB08059
The risk or severity of adverse effects can be increased when Butalbital is combined with Wortmannin.
DB08329
The risk or severity of adverse effects can be increased when Butalbital is combined with Sulthiame.
DB08550
The risk or severity of adverse effects can be increased when Butalbital is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
DB08810
The risk or severity of adverse effects can be increased when Butalbital is combined with Cinitapride.
DB08811
The risk or severity of adverse effects can be increased when Butalbital is combined with Tofisopam.
DB08839
The risk or severity of adverse effects can be increased when Butalbital is combined with Serotonin.
DB08872
The risk or severity of adverse effects can be increased when Butalbital is combined with Gabapentin enacarbil.
DB08892
The risk or severity of adverse effects can be increased when Butalbital is combined with Arbaclofen Placarbil.
DB08922
The risk or severity of adverse effects can be increased when Butalbital is combined with Perospirone.
DB08927
The risk or severity of adverse effects can be increased when Butalbital is combined with Amperozide.
DB08954
The risk or severity of adverse effects can be increased when Butalbital is combined with Ifenprodil.
DB08960
The risk or severity of adverse effects can be increased when Butalbital is combined with Hexamethonium.
DB08986
The risk or severity of adverse effects can be increased when Butalbital is combined with Etifoxine.
DB08992
The risk or severity of adverse effects can be increased when Butalbital is combined with Eperisone.
DB09000
The risk or severity of adverse effects can be increased when Butalbital is combined with Cyamemazine.
DB09001
The risk or severity of adverse effects can be increased when Butalbital is combined with Barbexaclone.
DB09011
The risk or severity of adverse effects can be increased when Butalbital is combined with Beclamide.
DB09014
The risk or severity of adverse effects can be increased when Butalbital is combined with Captodiame.
DB09017
The risk or severity of adverse effects can be increased when Butalbital is combined with Brotizolam.
DB09021
The risk or severity of adverse effects can be increased when Butalbital is combined with Benzoctamine.
DB09023
The risk or severity of adverse effects can be increased when Butalbital is combined with Benactyzine.
DB09068
The risk or severity of adverse effects can be increased when Butalbital is combined with Vortioxetine.
DB09071
The risk or severity of adverse effects can be increased when Butalbital is combined with Tasimelteon.
DB09118
The risk or severity of adverse effects can be increased when Butalbital is combined with Stiripentol.
DB09119
The risk or severity of adverse effects can be increased when Butalbital is combined with Eslicarbazepine acetate.
DB09128
The risk or severity of adverse effects can be increased when Butalbital is combined with Brexpiprazole.
DB09166
The risk or severity of adverse effects can be increased when Butalbital is combined with Etizolam.
DB09184
The risk or severity of adverse effects can be increased when Butalbital is combined with Edivoxetine.
DB09185
The risk or severity of adverse effects can be increased when Butalbital is combined with Viloxazine.
DB09186
The risk or severity of adverse effects can be increased when Butalbital is combined with Nisoxetine.
DB09187
The risk or severity of adverse effects can be increased when Butalbital is combined with Lortalamine.
DB09190
The risk or severity of adverse effects can be increased when Butalbital is combined with Talopram.
DB09194
The risk or severity of adverse effects can be increased when Butalbital is combined with Etoperidone.
DB09223
The risk or severity of adverse effects can be increased when Butalbital is combined with Blonanserin.
DB09224
The risk or severity of adverse effects can be increased when Butalbital is combined with Melperone.
DB09225
The risk or severity of adverse effects can be increased when Butalbital is combined with Zotepine.
DB09226
The risk or severity of adverse effects can be increased when Butalbital is combined with Brilaroxazine.
DB09241
The risk or severity of adverse effects can be increased when Butalbital is combined with Methylene blue.
DB09243
The risk or severity of adverse effects can be increased when Butalbital is combined with Hydracarbazine.
DB09244
The risk or severity of adverse effects can be increased when Butalbital is combined with Pirlindole.
DB09245
The risk or severity of adverse effects can be increased when Butalbital is combined with Toloxatone.
DB09246
The risk or severity of adverse effects can be increased when Butalbital is combined with Benmoxin.
DB09247
The risk or severity of adverse effects can be increased when Butalbital is combined with Iproclozide.
DB09248
The risk or severity of adverse effects can be increased when Butalbital is combined with Mebanazine.
DB09249
The risk or severity of adverse effects can be increased when Butalbital is combined with Octamoxin.
DB09250
The risk or severity of adverse effects can be increased when Butalbital is combined with Pheniprazine.
DB09251
The risk or severity of adverse effects can be increased when Butalbital is combined with Phenoxypropazine.
DB09252
The risk or severity of adverse effects can be increased when Butalbital is combined with Pivhydrazine.
DB09253
The risk or severity of adverse effects can be increased when Butalbital is combined with Safrazine.
DB09254
The risk or severity of adverse effects can be increased when Butalbital is combined with Caroxazone.
DB09290
The risk or severity of adverse effects can be increased when Butalbital is combined with Ramosetron.
DB11156
The risk or severity of adverse effects can be increased when Butalbital is combined with Pyrantel.
DB11371
The risk or severity of adverse effects can be increased when Butalbital is combined with Alfaxalone.
DB11376
The risk or severity of adverse effects can be increased when Butalbital is combined with Azaperone.
DB11400
The risk or severity of adverse effects can be increased when Butalbital is combined with Doramectin.
DB11428
The risk or severity of adverse effects can be increased when Butalbital is combined with Medetomidine.
DB11477
The risk or severity of adverse effects can be increased when Butalbital is combined with Xylazine.
DB11540
The risk or severity of adverse effects can be increased when Butalbital is combined with Propiopromazine.
DB11543
The risk or severity of adverse effects can be increased when Butalbital is combined with Romifidine.
DB11549
The risk or severity of adverse effects can be increased when Butalbital is combined with Tiletamine.
DB11552
The risk or severity of adverse effects can be increased when Butalbital is combined with Tricaine.
DB11555
The risk or severity of adverse effects can be increased when Butalbital is combined with Zolazepam.
DB11556
The risk or severity of adverse effects can be increased when Butalbital is combined with Detomidine.
DB11582
The risk or severity of adverse effects can be increased when Butalbital is combined with Thiocolchicoside.
DB11664
The risk or severity of adverse effects can be increased when Butalbital is combined with Psilocybin.
DB11675
The risk or severity of adverse effects can be increased when Butalbital is combined with Mosapride.
DB11686
The risk or severity of adverse effects can be increased when Butalbital is combined with Iferanserin.
DB11699
The risk or severity of adverse effects can be increased when Butalbital is combined with Tropisetron.
DB11755
The risk or severity of adverse effects can be increased when Butalbital is combined with Tetrahydrocannabivarin.
DB11859
The risk or severity of adverse effects can be increased when Butalbital is combined with Brexanolone.
DB11868
The risk or severity of adverse effects can be increased when Butalbital is combined with Etiracetam.
DB11889
The risk or severity of adverse effects can be increased when Butalbital is combined with Lanicemine.
DB11957
The risk or severity of adverse effects can be increased when Butalbital is combined with Idalopirdine.
DB12071
The risk or severity of adverse effects can be increased when Butalbital is combined with Vabicaserin.
DB12093
The risk or severity of adverse effects can be increased when Butalbital is combined with Tetrahydropalmatine.
DB12105
The risk or severity of adverse effects can be increased when Butalbital is combined with Imagabalin.
DB12110
The risk or severity of adverse effects can be increased when Butalbital is combined with m-Chlorophenylpiperazine.
DB12111
The risk or severity of adverse effects can be increased when Butalbital is combined with MK-212.
DB12131
The risk or severity of adverse effects can be increased when Butalbital is combined with Vinpocetine.
DB12163
The risk or severity of adverse effects can be increased when Butalbital is combined with Sarpogrelate.
DB12177
The risk or severity of adverse effects can be increased when Butalbital is combined with Eplivanserin.
DB12184
The risk or severity of adverse effects can be increased when Butalbital is combined with Gepirone.
DB12229
The risk or severity of adverse effects can be increased when Butalbital is combined with Cerlapirdine.
DB12273
The risk or severity of adverse effects can be increased when Butalbital is combined with Ecopipam.
DB12308
The risk or severity of adverse effects can be increased when Butalbital is combined with Eltanolone.
DB12327
The risk or severity of adverse effects can be increased when Butalbital is combined with Salvinorin A.
DB12338
The risk or severity of adverse effects can be increased when Butalbital is combined with Carisbamate.
DB12361
The risk or severity of adverse effects can be increased when Butalbital is combined with Piclozotan.
DB12395
The risk or severity of adverse effects can be increased when Butalbital is combined with Esreboxetine.
DB12401
The risk or severity of adverse effects can be increased when Butalbital is combined with Bromperidol.
DB12427
The risk or severity of adverse effects can be increased when Butalbital is combined with Orvepitant.
DB12465
The risk or severity of adverse effects can be increased when Butalbital is combined with Ketanserin.
DB12518
The risk or severity of adverse effects can be increased when Butalbital is combined with Raclopride.
DB12537
The risk or severity of adverse effects can be increased when Butalbital is combined with Benzodiazepine.
DB12576
The risk or severity of adverse effects can be increased when Butalbital is combined with AZD-3043.
DB12590
The risk or severity of adverse effects can be increased when Butalbital is combined with Indiplon.
DB12661
The risk or severity of adverse effects can be increased when Butalbital is combined with Urapidil.
DB12710
The risk or severity of adverse effects can be increased when Butalbital is combined with Perazine.
DB12725
The risk or severity of adverse effects can be increased when Butalbital is combined with TD-8954.
DB12833
The risk or severity of adverse effects can be increased when Butalbital is combined with Tandospirone.
DB12867
The risk or severity of adverse effects can be increased when Butalbital is combined with Benperidol.
DB12883
The risk or severity of adverse effects can be increased when Butalbital is combined with Eltoprazine.
DB12951
The risk or severity of adverse effects can be increased when Butalbital is combined with Pivagabine.
DB12958
The risk or severity of adverse effects can be increased when Butalbital is combined with Prothipendyl.
DB12989
The risk or severity of adverse effects can be increased when Butalbital is combined with Neosaxitoxin.
DB13014
The risk or severity of adverse effects can be increased when Butalbital is combined with Hypericin.
DB13025
The risk or severity of adverse effects can be increased when Butalbital is combined with Tiapride.
DB13082
The risk or severity of adverse effects can be increased when Butalbital is combined with Nefiracetam.
DB13099
The risk or severity of adverse effects can be increased when Butalbital is combined with Valnoctamide.
DB13213
The risk or severity of adverse effects can be increased when Butalbital is combined with Butaperazine.
DB13219
The risk or severity of adverse effects can be increased when Butalbital is combined with Medifoxamine.
DB13221
The risk or severity of adverse effects can be increased when Butalbital is combined with Apronalide.
DB13234
The risk or severity of adverse effects can be increased when Butalbital is combined with Propanidid.
DB13253
The risk or severity of adverse effects can be increased when Butalbital is combined with Proxibarbal.
DB13256
The risk or severity of adverse effects can be increased when Butalbital is combined with Clothiapine.
DB13273
The risk or severity of adverse effects can be increased when Butalbital is combined with Sultopride.
DB13295
The risk or severity of adverse effects can be increased when Butalbital is combined with Atracurium.
DB13303
The risk or severity of adverse effects can be increased when Butalbital is combined with Febarbamate.
DB13323
The risk or severity of adverse effects can be increased when Butalbital is combined with Trichloroethylene.
DB13324
The risk or severity of adverse effects can be increased when Butalbital is combined with Tetrazepam.
DB13331
The risk or severity of adverse effects can be increased when Butalbital is combined with Pyrithyldione.
DB13335
The risk or severity of adverse effects can be increased when Butalbital is combined with Pinazepam.
DB13352
The risk or severity of adverse effects can be increased when Butalbital is combined with Deanol.
DB13354
The risk or severity of adverse effects can be increased when Butalbital is combined with Phenprobamate.
DB13357
The risk or severity of adverse effects can be increased when Butalbital is combined with Styramate.
DB13362
The risk or severity of adverse effects can be increased when Butalbital is combined with Pheneturide.
DB13370
The risk or severity of adverse effects can be increased when Butalbital is combined with Bromisoval.
DB13377
The risk or severity of adverse effects can be increased when Butalbital is combined with Vinbarbital.
DB13382
The risk or severity of adverse effects can be increased when Butalbital is combined with Chlorproethazine.
DB13396
The risk or severity of adverse effects can be increased when Butalbital is combined with Neocitrullamon.
DB13402
The risk or severity of adverse effects can be increased when Butalbital is combined with Acetylglycinamide chloral hydrate.
DB13403
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxypertine.
DB13414
The risk or severity of adverse effects can be increased when Butalbital is combined with Fenyramidol.
DB13420
The risk or severity of adverse effects can be increased when Butalbital is combined with Thiazinam.
DB13437
The risk or severity of adverse effects can be increased when Butalbital is combined with Medazepam.
DB13455
The risk or severity of adverse effects can be increased when Butalbital is combined with Phenibut.
DB13457
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxaflozane.
DB13505
The risk or severity of adverse effects can be increased when Butalbital is combined with Emepronium.
DB13520
The risk or severity of adverse effects can be increased when Butalbital is combined with Metergoline.
DB13522
The risk or severity of adverse effects can be increased when Butalbital is combined with Mebicar.
DB13523
The risk or severity of adverse effects can be increased when Butalbital is combined with Veralipride.
DB13534
The risk or severity of adverse effects can be increased when Butalbital is combined with Gedocarnil.
DB13541
The risk or severity of adverse effects can be increased when Butalbital is combined with Iprazochrome.
DB13550
The risk or severity of adverse effects can be increased when Butalbital is combined with Bifemelane.
DB13552
The risk or severity of adverse effects can be increased when Butalbital is combined with Trifluperidol.
DB13554
The risk or severity of adverse effects can be increased when Butalbital is combined with Moperone.
DB13557
The risk or severity of adverse effects can be increased when Butalbital is combined with Thiopropazate.
DB13572
The risk or severity of adverse effects can be increased when Butalbital is combined with Emylcamate.
DB13577
The risk or severity of adverse effects can be increased when Butalbital is combined with Allobarbital.
DB13584
The risk or severity of adverse effects can be increased when Butalbital is combined with Gallamine.
DB13588
The risk or severity of adverse effects can be increased when Butalbital is combined with Naftidrofuryl.
DB13598
The risk or severity of adverse effects can be increased when Butalbital is combined with Diethyl ether.
DB13601
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxiracetam.
DB13623
The risk or severity of adverse effects can be increased when Butalbital is combined with Fabomotizole.
DB13642
The risk or severity of adverse effects can be increased when Butalbital is combined with Pridinol.
DB13643
The risk or severity of adverse effects can be increased when Butalbital is combined with Loprazolam.
DB13648
The risk or severity of adverse effects can be increased when Butalbital is combined with Alcuronium.
DB13662
The risk or severity of adverse effects can be increased when Butalbital is combined with Hexapropymate.
DB13665
The risk or severity of adverse effects can be increased when Butalbital is combined with Fluanisone.
DB13676
The risk or severity of adverse effects can be increased when Butalbital is combined with Mosapramine.
DB13687
The risk or severity of adverse effects can be increased when Butalbital is combined with Niaprazine.
DB13690
The risk or severity of adverse effects can be increased when Butalbital is combined with Vinyl ether.
DB13733
The risk or severity of adverse effects can be increased when Butalbital is combined with Methylpentynol.
DB13737
The risk or severity of adverse effects can be increased when Butalbital is combined with Cyclobarbital.
DB13745
The risk or severity of adverse effects can be increased when Butalbital is combined with Fazadinium bromide.
DB13754
The risk or severity of adverse effects can be increased when Butalbital is combined with Mephenoxalone.
DB13770
The risk or severity of adverse effects can be increased when Butalbital is combined with Vinylbital.
DB13784
The risk or severity of adverse effects can be increased when Butalbital is combined with Dixyrazine.
DB13791
The risk or severity of adverse effects can be increased when Butalbital is combined with Penfluridol.
DB13799
The risk or severity of adverse effects can be increased when Butalbital is combined with Ethadione.
DB13805
The risk or severity of adverse effects can be increased when Butalbital is combined with Reposal.
DB13817
The risk or severity of adverse effects can be increased when Butalbital is combined with Carbromal.
DB13837
The risk or severity of adverse effects can be increased when Butalbital is combined with Doxefazepam.
DB13841
The risk or severity of adverse effects can be increased when Butalbital is combined with Clopenthixol.
DB13872
The risk or severity of adverse effects can be increased when Butalbital is combined with Lormetazepam.
DB13875
The risk or severity of adverse effects can be increased when Butalbital is combined with Harmaline.
DB13876
The risk or severity of adverse effects can be increased when Butalbital is combined with Brofaromine.
DB13940
The risk or severity of adverse effects can be increased when Butalbital is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
DB13948
The risk or severity of adverse effects can be increased when Butalbital is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.
DB13984
The risk or severity of adverse effects can be increased when Butalbital is combined with Cyclopropane.
DB13993
The risk or severity of adverse effects can be increased when Butalbital is combined with MRK-409.
DB14010
The risk or severity of adverse effects can be increased when Butalbital is combined with 5-methoxy-N,N-dimethyltryptamine.
DB14028
The risk or severity of adverse effects can be increased when Butalbital is combined with Nordazepam.
DB14050
The risk or severity of adverse effects can be increased when Butalbital is combined with Cannabidivarin.
DB14509
The risk or severity of adverse effects can be increased when Butalbital is combined with Lithium carbonate.
DB14575
The risk or severity of adverse effects can be increased when Butalbital is combined with Eslicarbazepine.
DB14651
The risk or severity of adverse effects can be increased when Butalbital is combined with Perphenazine enanthate.
DB14672
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxazepam acetate.
DB14715
The risk or severity of adverse effects can be increased when Butalbital is combined with Cinazepam.
DB14718
The risk or severity of adverse effects can be increased when Butalbital is combined with Pyrazolam.
DB14719
The risk or severity of adverse effects can be increased when Butalbital is combined with Bentazepam.
DB14754
The risk or severity of adverse effects can be increased when Butalbital is combined with Solriamfetol.
DB15203
The risk or severity of adverse effects can be increased when Butalbital is combined with JNJ-26489112.
DB00967
The risk or severity of adverse effects can be increased when Butalbital is combined with Desloratadine.
DB00726
The risk or severity of adverse effects can be increased when Butalbital is combined with Trimipramine.
DB00216
The risk or severity of adverse effects can be increased when Eletriptan is combined with Butalbital.
DB00247
The risk or severity of adverse effects can be increased when Butalbital is combined with Methysergide.
DB00404
The risk or severity of adverse effects can be increased when Butalbital is combined with Alprazolam.
DB00593
The risk or severity of adverse effects can be increased when Butalbital is combined with Ethosuximide.
DB00683
The risk or severity of adverse effects can be increased when Butalbital is combined with Midazolam.
DB00897
The risk or severity of adverse effects can be increased when Butalbital is combined with Triazolam.
DB01200
The risk or severity of adverse effects can be increased when Butalbital is combined with Bromocriptine.
DB08815
The risk or severity of adverse effects can be increased when Butalbital is combined with Lurasidone.
DB12404
The risk or severity of adverse effects can be increased when Butalbital is combined with Remimazolam.
DB00751
The risk or severity of adverse effects can be increased when Butalbital is combined with Epinastine.
DB00604
The risk or severity of adverse effects can be increased when Butalbital is combined with Cisapride.
DB01356
The risk or severity of adverse effects can be increased when Butalbital is combined with Lithium cation.
DB00230
The therapeutic efficacy of Butalbital can be increased when used in combination with Pregabalin.
DB09124
The serum concentration of Medrogestone can be decreased when it is combined with Butalbital.
DB04844
The risk or severity of sedation and somnolence can be increased when Butalbital is combined with Tetrabenazine.
DB12161
The risk or severity of sedation and somnolence can be increased when Butalbital is combined with Deutetrabenazine.
DB09532
The therapeutic efficacy of Secretin human can be decreased when used in combination with Butalbital.
DB04948
The therapeutic efficacy of Butalbital can be increased when used in combination with Lofexidine.
DB14583
The metabolism of Segesterone acetate can be increased when combined with Butalbital.
DB01174
The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Butalbital.
DB01198
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Zopiclone.
DB00325
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Nitroprusside.
DB00435
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Nitric Oxide.
DB00727
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Nitroglycerin.
DB00883
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Isosorbide dinitrate.
DB01020
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Isosorbide mononitrate.
DB01612
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Amyl Nitrite.
DB00468
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Quinine.
DB06690
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Nitrous oxide.
DB00281
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Lidocaine.
DB00359
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Sulfadiazine.
DB00482
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Celecoxib.
DB00499
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Flutamide.
DB00608
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Chloroquine.
DB00698
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Nitrofurantoin.
DB00795
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Sulfasalazine.
DB00891
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Sulfapyridine.
DB01015
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Sulfamethoxazole.
DB01086
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Benzocaine.
DB01087
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Primaquine.
DB01435
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Antipyrine.
DB01438
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Phenazopyridine.
DB06706
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Isometheptene.
DB00252
The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Phenytoin.
DB00581
The therapeutic efficacy of Lactulose can be decreased when used in combination with Butalbital.
DB01046
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Butalbital.
DB01079
The therapeutic efficacy of Tegaserod can be decreased when used in combination with Butalbital.
DB01377
The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Butalbital.
DB01378
The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Butalbital.
DB01593
The therapeutic efficacy of Zinc can be decreased when used in combination with Butalbital.
DB01638
The therapeutic efficacy of Sorbitol can be decreased when used in combination with Butalbital.
DB04816
The therapeutic efficacy of Dantron can be decreased when used in combination with Butalbital.
DB04823
The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Butalbital.
DB04824
The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Butalbital.
DB07715
The therapeutic efficacy of Emodin can be decreased when used in combination with Butalbital.
DB08890
The therapeutic efficacy of Linaclotide can be decreased when used in combination with Butalbital.
DB09020
The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Butalbital.
DB09104
The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Butalbital.
DB09219
The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Butalbital.
DB09268
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Butalbital.
DB09281
The therapeutic efficacy of Magnesium trisilicate can be decreased when used in combination with Butalbital.
DB09287
The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Butalbital.
DB09311
The therapeutic efficacy of Polycarbophil can be decreased when used in combination with Butalbital.
DB09413
The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Butalbital.
DB09414
The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Butalbital.
DB09462
The therapeutic efficacy of Glycerin can be decreased when used in combination with Butalbital.
DB09472
The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Butalbital.
DB09481
The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Butalbital.
DB09484
The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Butalbital.
DB11057
The therapeutic efficacy of Mineral oil can be decreased when used in combination with Butalbital.
DB11059
The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Butalbital.
DB11089
The therapeutic efficacy of Docusate can be decreased when used in combination with Butalbital.
DB11097
The therapeutic efficacy of Plantago seed can be decreased when used in combination with Butalbital.
DB11110
The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Butalbital.
DB11113
The therapeutic efficacy of Castor oil can be decreased when used in combination with Butalbital.
DB11189
The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Butalbital.
DB11228
The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Butalbital.
DB11365
The therapeutic efficacy of Sennosides can be decreased when used in combination with Butalbital.
DB12942
The therapeutic efficacy of Lactitol can be decreased when used in combination with Butalbital.
DB13170
The therapeutic efficacy of Plecanatide can be decreased when used in combination with Butalbital.
DB13486
The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Butalbital.
DB13526
The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Butalbital.
DB13707
The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Butalbital.
DB14232
The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Butalbital.
DB14482
The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Butalbital.
DB14499
The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Butalbital.
DB14502
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Butalbital.
DB14503
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Butalbital.
DB14504
The therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Butalbital.
DB14513
The therapeutic efficacy of Magnesium can be decreased when used in combination with Butalbital.
DB14585
The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Butalbital.
DB14627
The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Butalbital.
DB14684
The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Butalbital.
DB14963
The therapeutic efficacy of Konjac mannan can be decreased when used in combination with Butalbital.
DB15477
The therapeutic efficacy of Alloin can be decreased when used in combination with Butalbital.
DB15478
The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Butalbital.
DB11622
The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Butalbital.
DB14516
The therapeutic efficacy of Sodium cation can be decreased when used in combination with Butalbital.
DB14546
The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Butalbital.
DB00191
The metabolism of Phentermine can be increased when combined with Butalbital.
DB00207
The metabolism of Azithromycin can be increased when combined with Butalbital.
DB00208
The metabolism of Ticlopidine can be increased when combined with Butalbital.
DB00426
The metabolism of Famciclovir can be increased when combined with Butalbital.
DB00518
The metabolism of Albendazole can be increased when combined with Butalbital.
DB00567
The metabolism of Cephalexin can be increased when combined with Butalbital.
DB01039
The metabolism of Fenofibrate can be increased when combined with Butalbital.
DB01072
The metabolism of Atazanavir can be increased when combined with Butalbital.
DB01098
The metabolism of Rosuvastatin can be increased when combined with Butalbital.
DB01411
The metabolism of Pranlukast can be increased when combined with Butalbital.
DB01431
The metabolism of Allylestrenol can be increased when combined with Butalbital.
DB01656
The metabolism of Roflumilast can be increased when combined with Butalbital.
DB06480
The metabolism of Prucalopride can be increased when combined with Butalbital.
DB08882
The metabolism of Linagliptin can be increased when combined with Butalbital.
DB09030
The metabolism of Vorapaxar can be increased when combined with Butalbital.
DB09048
The metabolism of Netupitant can be increased when combined with Butalbital.
DB09079
The metabolism of Nintedanib can be increased when combined with Butalbital.
DB09299
The metabolism of Tenofovir alafenamide can be increased when combined with Butalbital.
DB11094
The metabolism of Vitamin D can be increased when combined with Butalbital.
DB11273
The metabolism of Dihydroergocornine can be increased when combined with Butalbital.
DB11730
The metabolism of Ribociclib can be increased when combined with Butalbital.
DB11952
The metabolism of Duvelisib can be increased when combined with Butalbital.
DB12141
The metabolism of Gilteritinib can be increased when combined with Butalbital.
DB12515
The metabolism of 9-aminocamptothecin can be increased when combined with Butalbital.
DB12952
The metabolism of Methylprednisone can be increased when combined with Butalbital.
DB13345
The metabolism of Dihydroergocristine can be increased when combined with Butalbital.
DB13385
The metabolism of Dihydroergocryptine can be increased when combined with Butalbital.
DB14009
The metabolism of Medical Cannabis can be increased when combined with Butalbital.
DB14126
The metabolism of Tenofovir can be increased when combined with Butalbital.
DB00549
The metabolism of Zafirlukast can be increased when combined with Butalbital.
DB15444
The metabolism of Elexacaftor can be increased when combined with Butalbital.
DB12887
The metabolism of Tazemetostat can be increased when combined with Butalbital.
DB06717
The metabolism of Fosaprepitant can be increased when combined with Butalbital.
DB12825
The metabolism of Lefamulin can be increased when combined with Butalbital.
DB11742
The metabolism of Ebastine can be increased when combined with Butalbital.
DB11633
The metabolism of Isavuconazole can be increased when combined with Butalbital.
DB04572
The metabolism of Butalbital can be increased when combined with Thiotepa.
DB00188
The metabolism of Bortezomib can be increased when combined with Butalbital.
DB00248
The metabolism of Cabergoline can be increased when combined with Butalbital.
DB08910
The metabolism of Pomalidomide can be increased when combined with Butalbital.
DB00531
The metabolism of Cyclophosphamide can be increased when combined with Butalbital.
DB00204
The metabolism of Dofetilide can be increased when combined with Butalbital.
DB00277
The metabolism of Theophylline can be increased when combined with Butalbital.
DB00864
The metabolism of Tacrolimus can be increased when combined with Butalbital.
DB00877
The metabolism of Sirolimus can be increased when combined with Butalbital.
DB00908
The metabolism of Quinidine can be increased when combined with Butalbital.
DB00946
The metabolism of Phenprocoumon can be increased when combined with Butalbital.
DB01008
The metabolism of Busulfan can be increased when combined with Butalbital.
DB01100
The metabolism of Pimozide can be increased when combined with Butalbital.
DB01118
The metabolism of Amiodarone can be increased when combined with Butalbital.
DB01229
The metabolism of Paclitaxel can be increased when combined with Butalbital.
DB01254
The metabolism of Dasatinib can be increased when combined with Butalbital.
DB01320
The metabolism of Fosphenytoin can be increased when combined with Butalbital.
DB01396
The metabolism of Digitoxin can be increased when combined with Butalbital.
DB01590
The metabolism of Everolimus can be increased when combined with Butalbital.
DB04855
The metabolism of Dronedarone can be increased when combined with Butalbital.
DB06287
The metabolism of Temsirolimus can be increased when combined with Butalbital.
DB09289
The metabolism of Tianeptine can be increased when combined with Butalbital.
DB05239
The metabolism of Cobimetinib can be increased when combined with Butalbital.
DB09054
The metabolism of Idelalisib can be increased when combined with Butalbital.
DB09063
The metabolism of Ceritinib can be increased when combined with Butalbital.
DB09330
The metabolism of Osimertinib can be increased when combined with Butalbital.
DB11963
The metabolism of Dacomitinib can be increased when combined with Butalbital.
DB12015
The metabolism of Alpelisib can be increased when combined with Butalbital.
DB00540
The metabolism of Nortriptyline can be increased when combined with Butalbital.
DB00320
The metabolism of Dihydroergotamine can be increased when combined with Butalbital.
DB00696
The metabolism of Ergotamine can be increased when combined with Butalbital.
DB01242
The metabolism of Clomipramine can be increased when combined with Butalbital.
DB00872
The metabolism of Conivaptan can be increased when combined with Butalbital.
DB00637
The metabolism of Astemizole can be increased when combined with Butalbital.
DB08827
The metabolism of Lomitapide can be increased when combined with Butalbital.
DB12371
The metabolism of Siponimod can be increased when combined with Butalbital.
DB00563
The metabolism of Methotrexate can be increased when combined with Butalbital.
DB00361
The metabolism of Vinorelbine can be increased when combined with Butalbital.
DB00541
The metabolism of Vincristine can be increased when combined with Butalbital.
DB00570
The metabolism of Vinblastine can be increased when combined with Butalbital.
DB00997
The metabolism of Doxorubicin can be increased when combined with Butalbital.
DB01248
The metabolism of Docetaxel can be increased when combined with Butalbital.
DB05109
The metabolism of Trabectedin can be increased when combined with Butalbital.
DB05294
The metabolism of Vandetanib can be increased when combined with Butalbital.
DB08881
The metabolism of Vemurafenib can be increased when combined with Butalbital.
DB11363
The metabolism of Alectinib can be increased when combined with Butalbital.
DB11581
The metabolism of Venetoclax can be increased when combined with Butalbital.
DB11641
The metabolism of Vinflunine can be increased when combined with Butalbital.
DB11703
The metabolism of Acalabrutinib can be increased when combined with Butalbital.
DB13874
The metabolism of Enasidenib can be increased when combined with Butalbital.
DB15035
The metabolism of Zanubrutinib can be increased when combined with Butalbital.
DB00309
The metabolism of Vindesine can be increased when combined with Butalbital.
DB00398
The metabolism of Sorafenib can be increased when combined with Butalbital.
DB00675
The metabolism of Tamoxifen can be increased when combined with Butalbital.
DB00773
The metabolism of Etoposide can be increased when combined with Butalbital.
DB01268
The metabolism of Sunitinib can be increased when combined with Butalbital.
DB04845
The metabolism of Ixabepilone can be increased when combined with Butalbital.
DB04868
The metabolism of Nilotinib can be increased when combined with Butalbital.
DB06589
The metabolism of Pazopanib can be increased when combined with Butalbital.
DB06595
The metabolism of Midostaurin can be increased when combined with Butalbital.
DB06603
The metabolism of Panobinostat can be increased when combined with Butalbital.
DB06616
The metabolism of Bosutinib can be increased when combined with Butalbital.
DB06626
The metabolism of Axitinib can be increased when combined with Butalbital.
DB08865
The metabolism of Crizotinib can be increased when combined with Butalbital.
DB08870
The metabolism of Brentuximab vedotin can be increased when combined with Butalbital.
DB08877
The metabolism of Ruxolitinib can be increased when combined with Butalbital.
DB08901
The metabolism of Ponatinib can be increased when combined with Butalbital.
DB08912
The metabolism of Dabrafenib can be increased when combined with Butalbital.
DB09073
The metabolism of Palbociclib can be increased when combined with Butalbital.
DB09143
The metabolism of Sonidegib can be increased when combined with Butalbital.
DB09570
The metabolism of Ixazomib can be increased when combined with Butalbital.
DB11828
The metabolism of Neratinib can be increased when combined with Butalbital.
DB12147
The metabolism of Erdafitinib can be increased when combined with Butalbital.
DB12267
The metabolism of Brigatinib can be increased when combined with Butalbital.
DB12483
The metabolism of Copanlisib can be increased when combined with Butalbital.
DB12978
The metabolism of Pexidartinib can be increased when combined with Butalbital.
DB14568
The metabolism of Ivosidenib can be increased when combined with Butalbital.
DB00762
The metabolism of Irinotecan can be increased when combined with Butalbital.
DB06176
The metabolism of Romidepsin can be increased when combined with Butalbital.
DB06212
The metabolism of Tolvaptan can be increased when combined with Butalbital.
DB08896
The metabolism of Regorafenib can be increased when combined with Butalbital.
DB09074
The metabolism of Olaparib can be increased when combined with Butalbital.
DB11817
The metabolism of Baricitinib can be increased when combined with Butalbital.
DB12001
The metabolism of Abemaciclib can be increased when combined with Butalbital.
DB01128
The metabolism of Bicalutamide can be increased when combined with Butalbital.
DB05773
The metabolism of Trastuzumab emtansine can be increased when combined with Butalbital.
DB06772
The metabolism of Cabazitaxel can be increased when combined with Butalbital.
DB04896
The metabolism of Milnacipran can be increased when combined with Butalbital.
DB08918
The metabolism of Levomilnacipran can be increased when combined with Butalbital.
DB01256
The metabolism of Retapamulin can be increased when combined with Butalbital.
DB05077
The risk or severity of adverse effects can be increased when SLV319 is combined with Butalbital.
DB06155
The risk or severity of adverse effects can be increased when Rimonabant is combined with Butalbital.
DB06624
The risk or severity of adverse effects can be increased when Taranabant is combined with Butalbital.
DB09061
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butalbital.
DB11903
The risk or severity of adverse effects can be increased when GW842166 is combined with Butalbital.
DB12193
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Butalbital.
DB12649
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Butalbital.
DB13070
The risk or severity of adverse effects can be increased when Surinabant is combined with Butalbital.
DB13950
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Butalbital.
DB14011
The risk or severity of adverse effects can be increased when Nabiximols is combined with Butalbital.
DB14043
The risk or severity of adverse effects can be increased when Palmidrol is combined with Butalbital.
DB14737
The risk or severity of adverse effects can be increased when Cannabinol is combined with Butalbital.
DB00291
The therapeutic efficacy of Butalbital can be decreased when used in combination with Chlorambucil.
DB00397
The therapeutic efficacy of Butalbital can be decreased when used in combination with Phenylpropanolamine.
DB00422
The therapeutic efficacy of Butalbital can be decreased when used in combination with Methylphenidate.
DB00456
The therapeutic efficacy of Butalbital can be decreased when used in combination with Cefalotin.
DB00493
The therapeutic efficacy of Butalbital can be decreased when used in combination with Cefotaxime.
DB00719
The therapeutic efficacy of Butalbital can be decreased when used in combination with Azatadine.
DB00779
The therapeutic efficacy of Butalbital can be decreased when used in combination with Nalidixic acid.
DB00902
The therapeutic efficacy of Butalbital can be decreased when used in combination with Methdilazine.
DB00916
The therapeutic efficacy of Butalbital can be decreased when used in combination with Metronidazole.
DB00951
The therapeutic efficacy of Butalbital can be decreased when used in combination with Isoniazid.
DB01004
The therapeutic efficacy of Butalbital can be decreased when used in combination with Ganciclovir.
DB01061
The therapeutic efficacy of Butalbital can be decreased when used in combination with Azlocillin.
DB01598
The therapeutic efficacy of Butalbital can be decreased when used in combination with Imipenem.
DB01610
The therapeutic efficacy of Butalbital can be decreased when used in combination with Valganciclovir.
DB02136
The therapeutic efficacy of Butalbital can be decreased when used in combination with Cephalosporin analog.
DB03313
The therapeutic efficacy of Butalbital can be decreased when used in combination with Cephalosporin C.
DB03938
The therapeutic efficacy of Butalbital can be decreased when used in combination with Deacetoxycephalosporin C.
DB06793
The therapeutic efficacy of Butalbital can be decreased when used in combination with Levopropoxyphene.
DB09449
The therapeutic efficacy of Butalbital can be decreased when used in combination with Sodium phosphate, monobasic.
DB11199
The therapeutic efficacy of Butalbital can be decreased when used in combination with Sage oil.
DB11238
The therapeutic efficacy of Butalbital can be decreased when used in combination with Borage oil.
DB11358
The therapeutic efficacy of Butalbital can be decreased when used in combination with Evening primrose oil.
DB11447
The therapeutic efficacy of Butalbital can be decreased when used in combination with Phenothiazine.
DB13679
The therapeutic efficacy of Butalbital can be decreased when used in combination with Dexchlorpheniramine.
DB13854
The therapeutic efficacy of Butalbital can be decreased when used in combination with Gamolenic acid.
DB14071
The therapeutic efficacy of Butalbital can be decreased when used in combination with Desmethylsertraline.
DB01362
The therapeutic efficacy of Butalbital can be decreased when used in combination with Iohexol.
DB00822
The therapeutic efficacy of Butalbital can be decreased when used in combination with Disulfiram.
DB01218
The therapeutic efficacy of Butalbital can be decreased when used in combination with Halofantrine.
DB09555
The therapeutic efficacy of Butalbital can be decreased when used in combination with Dexchlorpheniramine maleate.
DB14256
The therapeutic efficacy of Butalbital can be decreased when used in combination with Centella asiatica.
DB00455
Butalbital may increase the anticholinergic activities of Loratadine.
DB14507
The therapeutic efficacy of Butalbital can be increased when used in combination with Lithium citrate.
DB14506
The therapeutic efficacy of Butalbital can be increased when used in combination with Lithium hydroxide.
DB09272
The risk or severity of constipation can be increased when Butalbital is combined with Eluxadoline.
DB00381
The metabolism of Amlodipine can be increased when combined with Butalbital.
DB01068
The metabolism of Clonazepam can be increased when combined with Butalbital.
DB11823
The risk or severity of adverse effects can be increased when Butalbital is combined with Esketamine.
DB00395
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Butalbital.
DB06711
The risk or severity of CNS depression can be increased when Naphazoline is combined with Butalbital.
DB08907
The serum concentration of Canagliflozin can be decreased when it is combined with Butalbital.
DB00402
The risk or severity of CNS depression can be increased when Butalbital is combined with Eszopiclone.
DB00564
Carbamazepine may increase the Change in thyroid function activities of Butalbital.
DB00575
The risk or severity of sedation can be increased when Clonidine is combined with Butalbital.
DB00843
The therapeutic efficacy of Butalbital can be decreased when used in combination with Donepezil.
DB11986
The metabolism of Entrectinib can be increased when combined with Butalbital.
DB00255
The metabolism of Diethylstilbestrol can be increased when combined with Butalbital.
DB00783
The metabolism of Estradiol can be increased when combined with Butalbital.
DB00977
The metabolism of Ethinylestradiol can be increased when combined with Butalbital.
DB01357
The metabolism of Mestranol can be increased when combined with Butalbital.
DB13954
The metabolism of Estradiol cypionate can be increased when combined with Butalbital.
DB13956
The metabolism of Estradiol valerate can be increased when combined with Butalbital.
DB00294
The metabolism of Etonogestrel can be increased when combined with Butalbital.
DB00304
The metabolism of Desogestrel can be increased when combined with Butalbital.
DB00351
The metabolism of Megestrol acetate can be increased when combined with Butalbital.
DB00367
The metabolism of Levonorgestrel can be increased when combined with Butalbital.
DB00396
The metabolism of Progesterone can be increased when combined with Butalbital.
DB00603
The metabolism of Medroxyprogesterone acetate can be increased when combined with Butalbital.
DB00717
The metabolism of Norethisterone can be increased when combined with Butalbital.
DB00823
The metabolism of Ethynodiol diacetate can be increased when combined with Butalbital.
DB00834
The metabolism of Mifepristone can be increased when combined with Butalbital.
DB00957
The metabolism of Norgestimate can be increased when combined with Butalbital.
DB01395
The metabolism of Drospirenone can be increased when combined with Butalbital.
DB04066
The metabolism of p-Coumaric acid can be increased when combined with Butalbital.
DB04574
The metabolism of Estrone sulfate can be increased when combined with Butalbital.
DB04682
The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Butalbital.
DB04839
The metabolism of Cyproterone acetate can be increased when combined with Butalbital.
DB05830
The metabolism of Trestolone can be increased when combined with Butalbital.
DB06266
The metabolism of Lonidamine can be increased when combined with Butalbital.
DB06713
The metabolism of Norelgestromin can be increased when combined with Butalbital.
DB06730
The metabolism of Gestodene can be increased when combined with Butalbital.
DB06789
The metabolism of Hydroxyprogesterone caproate can be increased when combined with Butalbital.
DB09123
The metabolism of Dienogest can be increased when combined with Butalbital.
DB09371
The metabolism of Norethynodrel can be increased when combined with Butalbital.
DB09389
The metabolism of Norgestrel can be increased when combined with Butalbital.
DB09401
The metabolism of Isosorbide can be increased when combined with Butalbital.
DB11507
The metabolism of Cloprostenol can be increased when combined with Butalbital.
DB11619
The metabolism of Gestrinone can be increased when combined with Butalbital.
DB11636
The metabolism of Nomegestrol can be increased when combined with Butalbital.
DB12025
The metabolism of Triptolide can be increased when combined with Butalbital.
DB12474
The metabolism of Lynestrenol can be increased when combined with Butalbital.
DB13044
The metabolism of Gossypol can be increased when combined with Butalbital.
DB13310
The metabolism of Ormeloxifene can be increased when combined with Butalbital.
DB13528
The metabolism of Chlormadinone can be increased when combined with Butalbital.
DB13563
The metabolism of Norgestrienone can be increased when combined with Butalbital.
DB13685
The metabolism of Quingestanol can be increased when combined with Butalbital.
DB13857
The metabolism of Demegestone can be increased when combined with Butalbital.
DB13866
The metabolism of Etynodiol can be increased when combined with Butalbital.
DB13944
The metabolism of Testosterone enanthate can be increased when combined with Butalbital.
DB13953
The metabolism of Estradiol benzoate can be increased when combined with Butalbital.
DB13981
The metabolism of Nomegestrol acetate can be increased when combined with Butalbital.
DB14678
The metabolism of Norethindrone enanthate can be increased when combined with Butalbital.
DB06804
The metabolism of Nonoxynol-9 can be increased when combined with Butalbital.
DB01611
The therapeutic efficacy of Hydroxychloroquine can be decreased when used in combination with Butalbital.
DB00924
The risk or severity of CNS depression can be increased when Butalbital is combined with Cyclobenzaprine.
DB01233
The risk or severity of sedation can be increased when Metoclopramide is combined with Butalbital.
DB11732
The risk or severity of adverse effects can be increased when Butalbital is combined with Lasmiditan.
DB11951
The serum concentration of Lemborexant can be decreased when it is combined with Butalbital.
DB06077
The serum concentration of Lumateperone can be decreased when it is combined with Butalbital.
DB00243
The metabolism of Ranolazine can be increased when combined with Butalbital.
DB00193
The metabolism of Tramadol can be increased when combined with Butalbital.
DB01190
The metabolism of Clindamycin can be increased when combined with Butalbital.
DB00246
The risk or severity of adverse effects can be increased when Butalbital is combined with Ziprasidone.
DB12457
The metabolism of Rimegepant can be increased when combined with Butalbital.
DB00502
The risk or severity of CNS depression can be increased when Butalbital is combined with Haloperidol.
DB11791
The serum concentration of Capmatinib can be decreased when it is combined with Butalbital.
DB15685
The serum concentration of Selpercatinib can be decreased when it is combined with Butalbital.
DB06283
The risk or severity of CNS depression can be increased when Butalbital is combined with Ziconotide.
DB00256
The metabolism of Lymecycline can be increased when combined with Butalbital.
DB00472
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.
DB14881
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Butalbital is combined with Oliceridine.